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ABSTRACT 
 The main objective of this Thesis was to encapsulate single viable cells within 
polyelectrolyte films using the Layer-by-Layer (LbL) technique. Most of the experiments 
used human mesenchymal stem cells (MSCs) whose characteristics (capacity of self-
renewal and potential to differentiate into several types of cells) make them particularly 
interesting to be used in biomedical applications. Also, most of the experiments used 
alginate (ALG) as the anionic polyelectrolyte and chitosan (CHI) or poly(allylamine 
hydrochloride) (PAH) as the cationic polyelectrolyte. Hyaluronic acid (HA) was also tested 
as an anionic polyelectrolyte. 
At the beginning of the work, the experimental conditions necessary to obtain the 
encapsulation of individual cells were studied and established. Through fluorescence 
microscopy visualization by staining the cell nucleus and using polyelectrolytes conjugated 
to fluorescent dyes, it was possible to prove the obtainment of capsules containing one 
single cell inside. Capsules aggregation was an observed problem which, despite the 
efforts to design an experimental process to avoid this situation (namely, by playing with 
cell concentration and different means of re-suspending and stirring the cells), was not 
completely overcome. 
In a second part of the project, single cells were encapsulated within polyelectrolyte 
layers made of CHI/ALG, PAH/ALG and PAH/HA and their viability was evaluated through 
the resazurin reduction assay and the Live/Dead assay. In these experiments, during the 
LbL process, polyelectrolyte solutions were used at a concentration of 1mg/mL based on 
literature. In general, the viability of the encapsulated cells was shown to be very 
low/absent. 
Then, as a consequence of the lack of viability of cells encapsulated within 
polyelectrolyte layers, the LbL technique was applied in cells growing adherent to the 
surface of cell culture plates. The cells were cultured like in a sandwich, between the 
surface of the cell culture dish and the polyelectrolyte layers. Also here, the polyelectrolyte 
solutions were used at a concentration of 1mg/mL during the LbL process. Surprisingly, cell 
viability was also absent in these systems. 
A systematic study (dose-effect study) was performed to evaluate the effect of the 
concentration of the individual polyelectrolytes (ALG, CHI and PAH were studied) in cell 
viability. Experiments were performed using cells growing adherent to the surface of cell 
culture plates. The results pointed out that a very high (cytotoxic) concentration of 
polyelectrolytes had been in use. Also, in general, PAH was much more cytotoxic than CHI, 
whereas ALG was the less cytotoxic polyelectrolyte. 
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 Finally, using alginate and chitosan solutions with adequate concentrations (low 
concentrations: 50ng/mL and 1µg/mL), the encapsulation of single viable cells was again 
attempted. Once again, the encapsulated cells were not shown to be viable. 
 In conclusion, the viability of the encapsulated cells is not only dependent on the 
cytotoxic characteristics (or combined cytotoxic characteristics) of the polyelectrolytes but it 
seems that, when detached from the culture plates, the cells become too fragile and lose 
their viability very easily. 
 
Keywords: Layer-by-layer technique; single cell encapsulation; chitosan, alginate; 
poly(allylamine hydrochloride), mesenchymal stem cells. 
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RESUMO 
O principal objectivo deste projecto foi o encapsulamento individual de células 
viáveis no interior de camadas formadas por polielectrólitos usando a técnica “Layer-by-
Layer” (LbL). As células estaminais mesenquimatosas humanas foram utilizadas na 
maioria dos procedimentos, uma vez que apresentam características únicas de auto-
renovação e diferenciação. A maioria das experiências usaram, sobretudo, o alginato 
(ALG) como polielectrólito negativo e o quitosano (CHI) e o poli(hidrocloreto de alilamina) 
(PAH) como polielectrólitos positivos. O ácido hialurónico (HA) também foi testado como 
polielectrólito negativo. 
No início do trabalho, foram estudadas as condições experimentais para a 
formação de cápsulas com uma única célula no seu interior. Usando a Microscopia de 
Fluorescência, através da marcação com sondas fluorescentes dos polielectrólitos e dos 
núcleos celulares, foi possível provar que se obtiveram cápsulas com uma única célula no 
seu interior. Um dos problemas observados durante o processo foi a agregação das 
cápsulas. Apesar dos esforços desenvolvidos para desenhar um procedimento 
experimental que evitasse esta situação (por exemplo, variando a concentração celular e 
os diferentes modos de ressuspender e agitar as células), não foi possível ultrapassar 
completamente este problema. 
Na segunda parte do trabalho, as células encapsuladas foram submetidas a testes 
de viabilidade, nomeadamente ao teste de redução da resazurina e ao teste “Live/Dead”. 
Nestas experiências, foram usadas cápsulas constituídas por CHI/ALG, PAH/ALG e 
PAH/HA, utilizando-se sempre uma concentração de 1mg/mL, com base em valores da 
literatura. Em geral, a viabilidade das células encapsuladas foi bastante baixa/nula.  
Seguidamente, em consequência da baixa viabilidade obtida nos ensaios 
anteriores, o método foi aplicado em células aderentes a uma placa de cultura. As células 
foram cultivadas, como numa “sandwich”, entre a superfície da placa de cultura e as 
camadas de polielectrólitos. Neste procedimento, foi também utilizada uma concentração 
de 1mg/mL para as soluções poliméricas. Surpreendentemente, também neste caso as 
células não se mostraram viáveis.  
Foi, então, feito um estudo sistemático (estudo “dose-efeito”) para avaliar o efeito 
da concentração dos polielectrólitos quando presentes individualmente (foram feitos 
estudos com o ALG, o CHI e o PAH). Estas experiências foram realizadas com as células 
aderentes à placa de cultura. Os resultados mostraram que estava a ser usada uma 
concentração muito elevada (tóxica) de polielectrólitos para encapsulamento das células. 
A partir destes estudos, também foi possível concluir que o PAH é mais tóxico que o CHI e 
que o ALG é o polielectrólito menos tóxico.  
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Finalmente, usando soluções de alginato e quitosano com concentrações 
adequadas (concentrações baixas: 50ng/mL e 1µg/mL), foi novamente efectuado o 
encapsulamento de células individuais. Verificou-se que, tal como anteriormente, as 
células encapsuladas não se mantiveram vivas.  
Concluindo, a viabilidade das células encapsuladas não depende apenas das 
características citotóxicas dos polielectrólitos (ou da combinação das suas características 
citotóxicas), mas parece que, uma vez retiradas da superfície da placa de cultura, as 
células ficam demasiado frágeis e perdem a sua viabilidade muito facilmente.  
 
Palavras-chave: Técnica camada-sobre-camada; encapsulamento de células únicas; 
quitosano, alginato, poli(hidrocloreto de alilamina), células estaminais mesenquimatosas. 
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CHAPTER 1 – INTRODUCTION 
 
1.1 The Layer-by-layer technique 
The classical layer-by-layer technique (LbL) was proposed by G. Decher in 1997 [1] 
and is based on the alternating adsorption of oppositely charged species (usually 
polyelectrolyte species) onto a charged template which can be a surface (2-dimensional 
template) or a particle (3-dimensional template; usually, a nano or microparticle). The 
process is illustrated in Figure 1 using a 3-dimensional template. Basically, for a positive 
template, the process begins with the initial electrostatic adsorption of a negatively charged 
polymer, followed by the adsorption of a positively charged one [2-31]. By repeating this 
procedure, a multilayer growth is possible, thus creating a film or a shell over the template 
with precision of thickness and roughness of less than 1 nm [2, 32]. 
The driving force of multilayer assembly has been extended to non-electrostatic 
interactions, including hydrogen bonding, covalent bonding, hydrophobic interactions, 
between others [3, 33-36]. The creation of multilayered polymer structures is a very 
versatile process and depends on the ability of the charged species to be adsorbed onto 
the top of an oppositely charged layer [1, 3-5, 37, 38]. Therefore, the templates and the 
polyelectrolyte pairs are very important components in the layer-by-layer technique [1, 3-5, 
37, 38]. 
When 3-dimensional templates are used, the removal of the internal template after 
the LbL deposition can give rise to empty cavities thus creating nanocapsules or 
macrocapsules [2-31] - this is also represented in Figure 1. These hollow and stable 
capsules contain an interior cavity and polymer walls which can be loaded and 
functionalized with a variety of substances such as dyes, drugs, nanoparticles and 
biomolecules [2, 4, 10, 13, 15, 39, 40]. To produce capsules, many templates can be used: 
biological cells, polystyrene latex particles, inorganic crystals (e.g. MnCO3, CaCO3, 
CdCO3), gold particles, colloidal particles, between others [4, 25, 29, 30, 31, 41-46]. The 
template should be stable under the LbL method and it also should be removable from the 
inside of the capsule, without providing any effect in terms of morphology, stability of the 
assembled layers on top of it [4]. The method of dissolving the core template depends on 
its nature and properties. There are works describing the dissolution of the core using 
ethylene diamine tetraacetic acid (EDTA) or a salt solution (“controlled precipitation” 
technique); another technique includes the pH<3 and a solvent, usually acetone and 
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ethanol, which makes the shell permeable to larger molecules (“permeability regulation” 
technique) [27, 47]. Other reagents can be used for core template dissolution, such as: 
tetrahydrofuran (THF), hydrochloric acid (HCl) and hydrofluoric acid (HF) [4, 27, 30]. The 
hollow capsules wall properties, like thickness, permeability, stability and biocompatibility 
can be designed and adjusted, as it is desired [5, 7, 24, 36, 38, 48]. 
These hollow capsules have attracted interest to be used as encapsulation systems, 
for example, as drug carrier systems (for instance dexamethasone [49, 50], insulin, vitamin 
K3 [51]), reaction vessels and nanoreactors (to prepare organic/inorganic hollow materials) 
[3, 15, 26, 27, 30, 38, 40, 43, 45, 48, 52], catalysis [3, 5, 26, 30, 36] and biosensing [5]. 
Other applications of hollow capsules include tools for implants and diagnostics [5]. 
Sometimes, a serious problem arises: the cytotoxicity of polyelectrolytes or of their 
metabolic products, after degradation [53, 54]. 
According to the literature, the polyions’ functional groups influence the cytotoxicity 
[54]. However, the literature also refers that there is a strong difference in toxicity if the 
polymer is inside the cell [54] or is only in contact with the membrane [55]. So, the same 
polyelectrolyte can induce both cell death or provide the adhesion of the cells to surfaces 
[55]. Furthermore, the investigations of de Rosa et al. [55] gave evidence that the surface 
charge also plays a crucial role in cell survival and adhesion of cells. 
Thanks to versatility of this technique, the two compartments of the capsules (shells 
and cavity) can be easily manipulated in order to create different types of systems, 
according to the specific requirements for a certain application [56, 57]. Compared to other 
traditional strategies, the LbL adsorption technique is an easy and inexpensive process for 
multilayer formation, and allows the incorporation of different types of materials in the film 
structures. Thus, this method can be regarded as a versatile bottom-up nanofabrication 
technique [57]. 
However, this technique has some drawbacks, such as: (i) high permeability to 
small molecules; (ii) aggregation, specifically of small capsules (< 1 mm in diameter); (iii) 
the reproducibility of results is low and (iv) long-term stability unknown [58].  
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Figure 1 - Schematic of polyelectrolyte capsule fabrication by layer-by-layer (LbL) assembly [4]. 
 
1.2 Cell Encapsulation 
 Cell encapsulation has the goal of entrapping viable cells within semi-permeable 
‘membranes’, which should be permeable for transport of molecules essential for cell 
survival [59-61]. This membrane must protect the inner cells from both mechanical stress 
and host’s immune system, while allowing the diffusion of oxygen, nutrients and waste [59, 
62].  
Bioencapsulation is a great method to create the appropriate interaction between 
cells and the microenvironment, leading to desired assemblies [6, 63]. Depending on the 
choice of material to create the capsule, and whether membranes are prefabricated or 
fabricated around viable cells, the cells will be submitted to different entrapment conditions 
[60]. An optimal equilibrium must be maintained among the several capsule properties to 
hold cell survival in a certain set of experimental conditions. As different types of cells have 
different metabolic requirements, the permeability of the capsules can depend on the 
choice of the cells [60]. In this way, the microenvironment of the all system can mimic the 
extracellular matrix or the culture conditions, where the cells to be encapsulated normally 
live [62].  
The encapsulation of cells in appropriate matrices has huge clinical applications, 
playing a very important role in cell and transplantation therapies.  This approach is used to 
create bioartificial organs in order to treat many human disorders, like diabetes [59, 60, 64], 
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Parkinson’s disease [59, 64], kidney failure [60, 64], hepatic failure [59] and amyotrophic 
lateral sclerosis (ALS) [64]. Other applications are related to cartilage replacement [59, 64], 
construction of replacement heart [64] and urinary valves [64], and artificial organs [62, 64]. 
The cell encapsulation systems are also denominated as “immunoprotective 
devices”, which means that these systems can protect the cells from immunodestruction 
caused by host antibodies and T-cells [60, 62, 64]. Encapsulation is not only a method for 
supporting/immobilizing and protecting cells, but can be also used has a vehicle for drug 
delivery. Each of these applications demands materials with specific physical, chemical, 
biomechanical, biological and degradation properties to provide an efficient therapy [59]. 
These encapsulation devices can constitute physically environments for study and control 
of biochemical processes [7, 12, 42, 63, 65]. 
Several methods for cell encapsulation, entrapment and coating within polymers 
and hydrogels have been investigated in the past. Beyond the LbL method, there are many 
others: “Gelation” or solidification, “Chemical Crosslinking”, “Ionic Crosslinking”, “Formation 
of an insoluble complex”, “One-stage Process”, between others [64].  
There are two different strategies for cell encapsulation: (i) microencapsulation and 
(ii) macroencapsulation. The first one is defined as the involucre of individual cells or small 
cell aggregates in a semipermeable membrane while the second corresponds to the 
utilization of hollow materials to deliver bigger aggregates of cells or multiple cells. The 
microencapsulation systems are usually small in its size and they are not taken from the 
patient, the devices are eliminated by the kidneys or by alternative ways. The 
macroencapsulation, on the other hand, has a superior mechanical integrity, but the 
obtained structures are not available for transport. Besides, these systems have a big 
disadvantage, because they can create problems from host proteins aggregating on their 
surfaces [60, 64]. 
 Many mammalian cells show an anchorage-dependent behaviour; this happens 
because in order to expose the best viability and the correct metabolic functionality, the 
cells must adhere to a surface or material. Therefore, the inner layer of the encapsulation 
material should provide suitable adhesion signals to the encapsulated cells. Moreover, the 
interaction of encapsulation matrices with the surrounding tissue in vivo is important as 
well, so that the outer layer of the matrix shouldn’t induce a host inflammatory response 
[64, 66]. Summarizing, it is very important to control and provide cell adhesion, even inside 
or outside the encapsulation matrix [64].  
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1.3 Encapsulation of single cells via the Layer-by-layer technique  
The LbL technique can be very useful and attractive for cell encapsulation 
applications, because it requires mild conditions and can be combined with shells 
functionalization [6, 67]. In particular, the encapsulation of living single cells inside 
polyelectrolyte layers can be very challenging has recognized by the few papers that were 
published in this subject.  
Alberto Diaspro and his colleagues [12] used the LbL method to encapsulate single 
yeasts (Saccharomyces cerevisiae, the common baker’s yeast). Their goals were to 
encapsulate living yeasts inside polymeric shells (made by poly(allylamine hydrochloride), 
PAH, and poly(sodium styrene sulfonate), PSS), using the LbL method. They used the 
fluorescent lipophilic cationic dye dimethylaminostyrylmethylpyridiniumiodine (DASPMI) to 
verify the metabolic activity of the yeasts and the Flow Cytometry technique to check the 
efficiency of cell encapsulation. They concluded that the polyelectrolyte coating didn’t 
influence cell metabolism and, in addition, that yeasts could even suffer division.  
T. Svaldo-Lanero and his co-workers [14] also used yeasts (Saccharomyces 
cerevisiae) and the LbL technique for encapsulation. They studied yeasts viability, 
mechanical properties and duplication capability, when encapsulated in polymeric shells 
made of PAH and PSS. To evaluate cell viability, they used dimethylpepep (D-pepep), a 
red dye which stains nuclear and mitochondrial DNA in living cells. In their study, they 
concluded that the internal cell structure was preserved and the duplication capability was 
verified.  
The encapsulation of animal cells using the LbL technique was also attempted. 
Nalinkanth G. Veerabadran and his co-workers [6] reported the encapsulation of rat 
Mesenchymal Stem Cells (MSCs) by using the LbL method. The polyelectrolyte shells were 
made of hyaluronic acid and poly(L-lisine). In this study, they demonstrated the ability to 
individually encapsulate animal cells within polymeric shells, as well as their capacity to 
survive until 7 days (by the MTT assay and the two-colour fluorescence Live/Dead Assay, 
assays that were also used in the present Master thesis). Before encapsulation, the 
PLL/HA capsules were characterized using Atomic Force Microscopy (AFM), ζ-potential 
measurements, Crystal Microbalance (QCM) monitoring and contact-angle measurements. 
Although the authors concluded that the LbL technique was a successful approach 
for single cell encapsulation, they also experienced some difficulties in evaluating cell 
viability using the MTT method, for which they used a time period greater than what would 
conventionally be used.   
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A very recent publication of Boon C. Heng and co-workers [68] described the partial 
coating of MSCs with polyelectrolytes (Figure 2). It is known that the binding of 
nanoparticles directly to the cell membrane can influence the cellular function by 
obstructing cell surface receptors. So, their goals were to investigate the use of polymer 
bilayers (hyaluronan (HA), poly-L-lysine(PLL) and chitosan (CHI); several concentrations 
were tested) to bind nanoparticles to MSCs, thus they developed a technique to obtain only 
half of the cell surface conjugated with nanoparticles via polyelectrolyte chains. They 
investigated both PLL/HA and CHI/HA pairs (used to create the polyelectrolyte bilayers) 
and verified that the best results were obtained by the chitosan/hyaluronan pair. 
Furthermore, they investigated the re-attachment and proliferation of the trypsin-
dissociated nanoparticle-conjugated MSCs. They concluded that they were able to re-
attach and proliferate cells over a period of 7 days after the freeze-thawing process. 
However, nanoparticles distribution was not uniform among the daughters.  
 
Figure 2 - Schematic representation of conjugating nanoparticles to bone marrow-derived MSCs via high 
molecular weight polyelectrolyte chains: poly-L-lysine, chitosan and hyaluronan [68]. 
 
Another work that deserves to be mentioned is that from Oliver Kreft and his co-
workers [13], although their goal was not to encapsulate living cells. In this case, they used 
erythrocytes as templates for capsules formation. The shells were made of PSS and PAH 
and, at the end, the human erythrocytes were dissolved, in order to obtain hollow capsules. 
The aim was to obtain capsules for encapsulation of DNA and HSA (‘human serum 
albumin’; coupled to a fluorescent dye: TRITC) using the LbL method. They reported that 
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the capsules were impermeable to DNA and HSA at the beginning (a) but, during drying, 
the permeability was ‘switched on’ and both compounds accumulated in the capsule 
interior and precipitated upon total drying (b, c); after re-suspension, the filled capsules 
were impermeable again (d) (Figure 3).  
 
Figure 3 - Schematic illustration of the encapsulation process [13]. 
 
 
1.4 Polyelectrolytes used in the LbL technique (special emphasis 
for those used in the Thesis) 
A polymer is a large molecule composed by repeating structural units, usually linked 
by covalent bonds. They can be synthetic for instance, such as polystyrene, PVB, PVC 
[69], between others, or called biopolymers, which include polysaccharides, polypeptides 
and polynucleotides [13, 42, 47, 56, 58, 61, 70-72]. Polymers can work as polyelectrolytes - 
species with charged or chargeable groups, when dissolved in polar solvents [73]. 
Additionally, these materials can be divided into those where the charge density 
depends on pH (weak polyelectrolytes) and those for which the charge density is 
independent of pH (strong polelectrolytes) (see examples in Table 1) [64].   
  In the biomedical area, many polymers have been investigated, like PAH, PSS, HA, 
PLL, CHI, alginate (ALG), between others (see examples in Table 1) [5, 9, 31, 58, 64, 74]. 
The capsules constituted by PAH and PSS are the best characterized 
polyelectrolyte multilayered systems in the literature [10]. The poly(sodium styrene 
sulfonate) (PSS) is a strong polyanion and poly(allylamine hydrochloride) (PAH) is a 
relatively weak polycation, sensitive to pH changes, a fact that can have an influence in the 
inter-polyelectrolyte interactions [11-14]. This pair of polyelectrolytes has been extensively 
used for the fabrication of multilayers on flat and colloidal surfaces [74]. The success of 
these materials in in vivo applications requires the maintenance of not only the cell viability, 
but also of the desired cellular metabolism [64]. For this purpose, it is possible to employ 
natural, polyelectrolyte thin-films coatings, which can modulate the cell permeability and 
influence cellular function, without compromising the cell viability [6]. 
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The capsules can also, beyond polysaccharides, polypeptides and polynucleotides, 
be made by lipids, dyes and inorganic nanoparticles, proteins [11, 13, 25, 28, 29, 33, 39, 
40, 42, 43, 45-48, 58, 74, 75]. The capsule wall composition has a relevant role for the 
creation of functional capsules, because their permeability depends on the chemical 
structure and the molecular weight of the polyelectrolyte layers [4]. 
 
Table 1 - Characteristics of some polyelectrolytes used for cell encapsulation [64]. 
System Notes 
Alginate Strong polyanion 
Carrageenan Strong polyanion 
Poly(styrene sulfonate) Strong polyanion 
Carboximethylcelluose Polyanion 
Cellulose sulphate Polyanion 
Heparin Polyanion 
Poly(methylene-co-guanidine) Polyanion 
Poly(diallyldimethyl ammonium chloride) Strong polyanion 
Chitosan 
Weak polycation, pKa of primary amine 
6,3 – 6,8 
Poly(L-lysine) 
Weak polycation, pKa of primary amine 
~10,5 
Poly(allylamine) Hydrochloride 
Weak polycation, pKa of amine group 
~8,5 
Poly(vinylamine) Hydrochloride Weak polycation 
 
 
1.4.1 ALGINATE AND CHITOSAN 
 Since 1998, polyelectrolyte microcapsules have attracted a great interest, because 
their properties, including size, composition, shape, thickness, permeability, stability and 
stiffness can be tailored easily [7, 33, 37, 47, 56]. Polysaccharides are particularly used 
due to their hydrophilic and protective properties and to their biodegradable and compatible 
capacities as well [30, 61, 76]. 
Natural polysaccharides such as alginate and chitosan (Figure 4) have been 
investigated for applications in several functions: drug delivery, coating membranes and for 
biomaterials research [8, 30, 41]. The use of alginate in the encapsulation of animal cells 
has been very successful, due to the absence of toxic components in this polymer [77, 78]. 
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The negatively charged carboxylic acid groups of manuronic and guluronic acid 
units present in alginate molecule can interact electrostatically with the positively charged 
amino groups of chitosan, producing a polyelectrolyte complex. Alginate is one of the most 
studied anionic polyelectrolytes in assemble with chitosan, because the formed complex is 
still biodegradable and biocompatible [76, 79]. 
  
 
Figure 4 - Alginate and Chitosan structures [8]. 
 
Alginate is an anionic polymer obtained from marine brown algae [8, 61, 79]. It is a 
linear binary copolymer composed by two kinds of residues: (1J4)−linked 
β−D−mannuronic acid (M) and α−L−guluronic acid (G) (Figure 5) [30, 45, 61, 76, 77, 79]. 
The distribution of these monomers along the alginate chain is very important, 
because it will influence its properties [66, 77]. The properties of each monomer of 
alginates have previously been reported, and the pKa-values for mannuronic acid and for 
guluronic acid are 3.38 and 3.65, respectively [76]. 
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Figure 5 - Alginate  composition: A - Mannuronic acid  residues chain;  B - Guluronic acid residues chain; C - 
both residues  (randomly) [80]. 
 
 Chitosan (Figure 6) is a natural cationic polymer obtained from the deacetylation of 
chitin (a copolymer of β(1→4) linked N-acetyl-D-glucosamine [81]) [8, 30, 65, 79, 82, 83], 
which is a product found in crustacean shells [30, 65, 68, 76, 81, 83]. In this reaction (made 
by chitin-deacetylase enzyme), some units of chitin lost their acetyl group, creating 
deacetylated units. So, it is a linear binary copolymer composed by β-(1-4)-D-glucosamine 
(deacetylated unit) and N-acetyl-D-glucosamine (acetylated unit). Both residues are 
randomly distributed along the chitosan chain [65, 76, 79, 84].  
Relatively to its solubility, chitosan is a weak base and is insoluble in water and 
organic solvents, but it is soluble in dilute aqueous acidic solutions (pH < 6.5), which can 
make the glucosamine units soluble: R–NH3+. Chitosan gets precipitated in alkaline solution 
or with polyanions and forms a gel at lower pH [83]. 
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Figure 6 - Scheme showing the deacetylation of chitin to produce chitosan. The deacetylated units are marked 
with a purple circle; the acetyl group is marked with a blue circle and the acetylated units with a green one1. 
 
Chitosan shows great biological properties such as: biocompatibility, biodegradation 
in the human body, and immunological, antibacterial and wound-healing activity.  In recent 
studies, chitosan has shown capacities to be used as a support material for many 
applications: gene delivery, cell culture, and tissue engineering. Therefore, chitosan is 
receiving a huge attention as a new functional material [65, 79, 81, 82, 85, 86].  
 
1.4.2 HYALURONIC ACID 
Hyaluronic acid (HA) is also a polysaccharide. It is a glycosaminoglycan (GAG), 
because one of the sugars used in its structure is modified with an amino group (-NH2). It is 
a polymer of disaccharides, themselves composed by D-glucuronic acid and D-N-
acetylglucosamine, linked together via alternating β-(1,4) and β-(1,3) glycosidic bonds 
(Figure 7) [6, 15, 87]. HA is present in almost all biological tissues and body fluids. HA 
presents important physiological functions in living organisms, which make it an attractive 
biomaterial for many medical purposes [87]. It presents a good biocompatibility and 
biodegradability, therefore, it can be used for several drug delivery applications [15]. 
                                                            
1 The references of all figures are presented in the Credits List (at the end of this thesis), except for those which were taken 
from articles, identified with numbers. 
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Figure 7 - Hyaluronic acid structure. 
 
In clinical medicine, HA is used as a diagnostic marker for many diseases, such as 
rheumatoid arthritis, cancer and liver disorders. It is also used in ophthalmological and 
ontological surgeries and cosmetic regeneration and reconstruction of tissue. This polymer 
can immobilize water in tissue and change dermal volume and compressibility. It can also 
influence cell proliferation, differentiation, and tissue repair, between other biological 
functions [87]. 
 
1.4.3 COLLAGEN 
 Collagen represents the most common structural protein in the vertebrate body 
(approximately 30%). There are at least 13 types of collagen, which have been isolated in 
respect to the length of the helix and the nature and size of the non-helical areas (Table 2) 
[88]. 
Type I collagen is the most found in animals, namely in the skin, tendon, and bone. 
Structurally, it is a compound of three chains, two of which are identical: α1(I), and 
one α2(I) chain with different amino acid composition. Basically, the collagen molecule 
contains three polypeptide α-chains, each with more than 1000 amino acids (Figure 8) [88]. 
Collagen can be processed into tubes, sheets, powders, sponges, fleeces, 
injectable solutions and dispersions, all of which have found use in medical purposes. 
Moreover, these systems have been used for drug delivery for several applications, 
including ophthalmology, wound and burn dressing, tissue engineering and tumour 
treatment [88]. 
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Table 2 - Chain composition and body distribution of collagen types [88]. 
Collagen 
Type Chain composition Tissue distribution 
I (α1(I))2α2(I), trimer (α1(I))3 
Skin tendon, bone, cornea, dentin, 
fibrocartilage, large vessels, intestine, 
uterus, dermis 
II (α1(II))3 
Hyaline cartilage, vitreous, nucleus 
pulposus, notochord 
III (α1(III))3 
Large vessels, uterine wall, dermis, 
intestine, heart valve, gingival (usually 
coexists with type I except in bone, tendon, 
cornea) 
IV (α1(IV))2α2(IV) Basement membranes 
V α1(V)α2(V)(3(V)) or (α1(V))2α2(V) or (α1(V))3 
Cornea, placental membranes, bone, large 
vessels, hyaline cartilage, gingiva 
VI α1(VI)α2(VI)α3(VI) Descemet’s membrane, skin, nucleus pulposus, heart muscle 
VII (α1(VII))3 Skin, placenta, lung, cartilage, cornea 
VIII 
α1(VIII) α2(VIII) chain 
organization of helix 
unknown 
Produced by endothelial cells, Descemet’s 
membrane 
IX α1(IX)α2(IX)α3(IX) Cartilage 
X (α1(X))3 Hypertrophic and mineralizing cartilage 
XI 1α2α3α1 or α1(XI)α2(XI)α3(XI) 
Cartilage, intervertebral disc, vitreous 
humour 
XII (α1(XII))3 
Chicken embryo tendon, bovine periodontal 
ligament 
XIII Unknown Cetal skin, bone, intestinal mucosa 
 
 
Figure 8 - Collagen structure. 
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1.4.4 POLY(ALLYLAMINE HYDROCHLORIDE) 
The PAH (poly(allylamine hydrochloride)) is another polyelectrolyte which can be 
used in the encapsulation field [8-10, 58, 64]. The PAH, also denominated as PAA or 
PAAH is a cationic polyelectrolyte prepared by the polymerization of allylamine (Figure 9) 
[10]. 
 
 
Figure 9 - Poly(allylamine hydrochloride) structure (Mw~56,000Da). 
 
The PAH is one of the most used polymer for the fabrication of capsules [10-14, 70]. 
In particular, PAH has been used as a model cationic polyelectrolyte for DNA and proteins 
for preparation of hollow microcapsules using the Layer-by-layer method [89]. 
It is a weak polycation, with a pKa of amine group ∼ 8.5 [64, 90, 91]. Being a weak 
polycation, the change of pH or ionic strength will alter the PAH conformation [64, 92, 93]. 
 Not only the conformation, but also the thickness (of the layers or capsules made 
by this polymer) is sensitive to solution pH, due to the fact that the charge density of a 
weak polyelectrolyte can be varied by the changing of pH. The PAH is positively charged at 
low and neutral pH, but at high pH, it leads to the dissociation of H+ ions and forms a 
structure with uncharged amine groups [94]. 
 
1.5 Mesenchymal Stem Cells (MSCs) 
Nowadays, “Stem cells” is a very important topic in Biology.  It is thought that their 
unique properties can provide a huge number of answers to some questions in biology, as 
well as possible treatments for several degenerative diseases and applications in tissue 
engineering [67, 95, 96]. Stem cells are unique, because they have the capacity to self-
renewal and to differentiate into a several types of cells (including chondrocytes, 
osteoblasts, adipocytes, nervous cells, blood cells) (Figure 10) [6, 67, 95-97].  
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Figure 10 - The origin, isolation, and specialization of stem cells. 
 
These cells are usually classified in embryonic stem cells (ESCs) and adult stem 
cells. The first ones are pluripotent due to their capability to origin all kinds of cells. The 
ESCs can be obtained from the early mammalian embryo at the blastocyst stage and using 
specific culture conditions, they have the capacity to expand unlimited in vitro and 
differentiate. On the other hand, adult stem cells are multipotent and are derived from many 
tissues such as bone, brain, adipose tissue, umbilical cord blood, blood vessels, blood, 
between others [95, 97]. 
The “mesenchymal stem cells” (a term used by Arnold Caplan for the first time in 
1991) often receive other designations such as “marrow stromal cells”, “precursors of non-
hematopoietic tissue”, “colony forming unit fibroblasts” or “multipotent adult progenitor cells” 
[98]. MSCs are multipotent adult stem cells, nonhematopoietic which can be derived from 
mesoderm and neuroectoderm. This cell type can be found in most postnatal organs and 
tissues, namely in the bone marrow (BM). They are able to differentiate not only into cells 
of mesodermal origin such adipocytes, chondrocytes, osteocytes (Figure 11), tenocytes, 
skeletal and myocytes, but also into representative lineages of the three embryonic layers, 
such as neurons (from ectoderm) and hepatocytes (from endoderm) [97, 99-101].  
The adult mesenchymal stem cells (MSCs), besides being multipotent, are easily 
isolated and cultured in vitro and, a great advantage, is that the use of this kind of cells do 
not raise ethical issues related with their origin. These cells have been considered an 
important tool for several clinical applications, due to some of their characteristics: they 
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present an optimal expansion potential and genetic stability; there are well established 
protocols for their isolation and new sources keep on showing up, beyond the already 
existing ones. In addition, MSCs are able to migrate to areas of tissue damage in immune 
privileged conditions, presenting immunosuppressive properties. All these advantages 
have provided many successful MSCs transplantations [97, 99, 100]. Other applications 
are bone, cartilage, tendon and skeletal muscle repair [101]. 
 
 
 
Figure 11 - Culture-expanded human mesenchymal stem cells exhibit a spindle-shaped fibroblastic morphology 
following culture expansion ex vivo. Under appropriate inducing conditions, the culture will demonstrate 
adipogenic differentiation, chondrogenic differentiation or osteogenesis [99]. 
 
1.6 Objectives & General Strategy of the Thesis 
The principal aim of this Thesis was to encapsulate single viable cells within 
polyelectrolyte films using the Layer-by-Layer (LbL) technique. Due to their characteristics 
and potential to be applied in the biomedical field, human mesenchymal stem cells (MSCs) 
were used in the great majority of the experiments. The first experiments used alginate 
(ALG) as the anionic polyelectrolyte and chitosan (CHI) as the cationic polyelectrolyte as 
they are natural polymers known to be biocompatible.  As a consequence of the lack of 
viability of the cells encapsulated within CHI/ALG capsules, other polyeletrolytes were also 
tested for the same purpose: poly(allylamine hydrochloride) (PAH) and hyaluronic acid 
(HA). 
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Figure 12 shows the general strategy followed in the present Thesis. First, the 
experimental conditions necessary to obtain the encapsulation of individual cells were 
studied and established. 
Several type of cells were used in these studies (NIH 3T3, rMSCs and hMSCs) and 
polyelectrolyte solutions of 1mg/mL (this concentration was chosen based on literature) 
were used in the encapsulation process. Single cell encapsulation was assessed by 
fluorescence microscopy. 
Second, the viability of cells encapsulated within CHI/ALG layers was evaluated 
(assessed both by the resazurin reduction assay and the Live/Dead assay) and, as the 
results were not satisfactory, cells were also encapsulated the pairs of polyelectrolytes 
PAH/ALG and PAH/HA. NIH 3T3 and hMSCs were used in these experiments, together 
with polyelectrolyte solutions of 1mg/mL. 
Once again, cell viability was very low/absent. The LbL technique was then applied 
in cells growing adherent to the surface of cell culture plates. The cells (hMSCs) were 
cultured like in a sandwich, between the surface of the cell culture dish and the 
polyelectrolyte layers made of PAH/ALG. Also here, the polyelectrolyte solutions were used 
at a concentration of 1mg/mL during the LbL process. Surprisingly, cell viability was also 
absent in these systems. This set of results pointed out the need for a systematic study 
(dose-effect study) concerned with the evaluation of the effect of the concentration of the 
individual polyelectrolytes (ALG, CHI and PAH were studied) in cell viability. Experiments 
were performed using cells (hMSCs) growing adherent to the surface of cell culture plates 
and polyelectrolyte concentrations varying from 0 to 500µg/mL. As a conclusion from these 
studies, very high (cytotoxic) concentration of polyelectrolytes had been in use. Also, in 
general, PAH was much more cytotoxic than CHI, whereas ALG was the less cytotoxic 
polyelectrolyte. So, as a last experiment, alginate and chitosan solutions with adequate 
concentrations (low concentrations: 50ng/mL and 1µg/mL), were applied in the 
encapsulation of single hMSCs. Once again, the encapsulated cells were not shown to be 
viable.  
The next chapters describe in more detail the strategy here presented. Although the 
objective main goal of the Thesis was not fully accomplished, the work developed under its 
scope allowed interesting observations and to draw some conclusions. 
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Figure 12 - General strategy followed in the work. 
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CHAPTER 2 – MATERIALS AND METHODS 
 
2.1 Cells and cell culture 
Fibroblasts (NIH 3T3) and mesenchymal stem cells (MSCs) derived from the bone 
marrow of rats and humans were used in the experiments. The NIH 3T3 cell line was gently 
offered by INEB (University of Porto). Rat MSCs were isolated from the femora of 8-week-
old male Wistar rats (Charles River Laboratories, Spain). Following euthanasia by 
pentobarbital 20% (v/v), the bones were aseptically excised, cleaned of soft tissue, and 
washed in a saline solution. The bone metaphyseal ends were cut off and the marrow was 
flushed out from the mid shaft with α-Minimum Essential Medium (α-MEM) using a syringe. 
The human cells were isolated from the bone marrow present in the trabecular bone 
of healthy adults which was obtained during surgery interventions after trauma. Only tissue 
that would have been discarded was used, with the approval of the Ethical Local 
Committee.  After establishment of a primary culture and expansion of the cells in culture 
(cell passages were done using trypsin-EDTA from GIBCO®), cells were frozen using the 
standard procedures [66]. After, when needed, cells were thawed and placed in culture 
also using the normal procedures [66]. 
All cell cultures were incubated at 37ºC, in a humidified atmosphere of 95% air and 
5% carbon dioxide. NIH 3T3 cells were cultured in D-MEM (by GIBCO®) and the MSCs 
(both from rat and human origin) were cultured in α-Minimum Essential Medium Eagle (α-
MEM, GIBCO®) with 10% Fetal Bovine Serum (FBS, GIBCO® ) and 2% of an antibiotic-
antimycotic solution (GIBCO®, with 10,000 units penicillin/ml, 10mg streptomycin/ml and 
25μg amphotericin B/ml). All cell culture dishes were from NUNC. 
 
2.2 Equipments, materials and reagents  
An incubator (NUAIRE, Autoflow IR Direct Heat CO2 incubator), a laminar flow hood 
(NUAIRE, Class II A/B3), an inverted optical microscope (OLYMPUS, CK40), an inverted 
fluorescence microscope (NIKON, TE2000), a microplate reader (PerkinElmer VICTOR3™) 
an autoclave (ajc®) and a rotary evaporator (Buchi, R210) were used in the experimental 
work when needed.  
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The dialysis membranes were from Spectrum®labs and the filters used for solution 
sterilization were from VWR™ with a pore size of 0.22µm.  
Five different polymers were used in this work: alginate (MMW (50-120kDa), 
SIGMA®); chitosan (85% deacetylated, SIGMA®), PAH (MW ∼ 56000Da, Aldrich®), 
hyaluronic acid (MW=1.63x106kDa, BioChemika®,) and collagen (Native Calf Skin Collagen 
Type I, IBFB, Germany).  
PBS (GIBCO®, without calcium or magnesium), calcium chloride (ACROS®), 
magnesium chloride (MERCK®), magnesium sulphate (MERCK®), potassium chloride 
(Riedel-de Haën®), potassium phosphate monobasic (MERCK®), sodium bicarbonate 
(MERCK®), sodium chloride (MERCK®), sodium phosphate dibasic (Riedel-de Haën®), 
glucose (MERCK®), acetic acid (Riedel-de Haën®), EDTA (MERCK®) were used in the 
preparation of several solutions during the experimental work.  
DAPI (SIGMA®), DTAF (SIGMA-ALDRICH®) and RITC (FLUKA®) were used in the 
staining procedures. 
The methods applied in the evaluation of cell viability used resazurin (ALDRICH®), 
the MTT reagent (SIGMA®), PI (SIGMA-ALDRICH®) and FDA (SIGMA®).  
 
2.3 Preparation of solutions  
The polymeric solutions (of alginate, PAH and HA) were prepared in NaCl 0.15M at 
1mg/mL. The pH of each of these solutions was between 7 and 8 (alginate: pH=7.4; PAH: 
pH=7.2; HA: pH=7.28). The CHI was dissolved (1%) (w/v) in a solution containing acetic 
acid (0.1M) and NaCl (0.15M). The CHI was allowed to dissolve overnight with a gentle 
stirring. Then, the pH of the solution was adjusted to 4.1 (without suspended particles 
formation) and the solution was filtrated under vacuum. All the polymer solutions were 
sterilized (with a 0.22 µm membrane and a syringe, inside the laminar flow chamber) and 
kept in the fridge at 4ºC. All the glassware and other materials were sterilized in an 
autoclave, to avoid any kind of contamination.   
 The collagen was prepared from a mother solution (2mg/mL, prepared in 0.1M 
acetic acid) using a NaCl solution (0.15M) and sterilized as well, with a final concentration 
of 100µg/mL.  
The α-MEM (stock) was prepared adding 10.08g of the commercial powder and 
2.2g of NaHCO3 to 1L of distilled water. The pH was checked and the solution was 
sterilized. To prepare supplemented α-MEM (200mL), 2mL of the antibiotic-antimycotic 
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solution, 20mL of serum and 178mL of α-MEM (stock). This mixture was maintained in the 
fridge at 4ºC.  
For the Phosphate Buffered Saline (PBS) solution preparation, 9.55g of PBS 
powder was dissolved in 1L of distilled water. The pH was checked and the solution was 
sterilized. 
The Hank’s Balanced Salt Solution (HBSS, 1x) was prepared by adding the 
following reagents (with their final concentrations in solution): calcium chloride (140mg/mL); 
magnesium chloride (100mg/mL); magnesium sulphate (100mg/mL); potassium chloride 
(400mg/mL); potassium phosphate monobasic (60mg/mL); sodium bicarbonate 
(350mg/mL); sodium chloride (8000mg/mL); sodium phosphate dibasic (48mg/mL) and 
glucose (1000mg/mL) [102]. The pH was established to 6.65 and the solution was sterilized 
with a 0.22µm membrane.   
 The resazurin reagent was prepared by mixing 0.02g of resazurin with 200mL of 
PBS (1x). This solution was sterilized (with a 0.22µm membrane and a syringe, inside de 
laminar flow hood chamber), distributed in smaller tubes and kept at -20ºC.  
 The MTT reagent was prepared adding 100mg of MTT to 20mL of PBS. This 
solution was sterilized (with a 0.22µm membrane and a syringe inside de chamber), 
distributed in smaller tubes and kept at -20ºC.  
For the Live/Dead assay, two specific dyes were used: the PI and the FDA. The first 
one was used at 1mg/mL (it was not prepare in the lab) and FDA with a concentration of 
5mg/mL in acetone. 
 
2.4 Alginate and chitosan fluorescent labelling  
To prepare the DTAF-labelled ALG solution, 15.0mL of ALG solution (1mg/mL) was 
mixed with 8mg of DTAF (the pH was adjusted to a value superior than 11 with NaOH) and 
it was allowed to react overnight, at room temperature, with gentle stirring, covered with 
foil. The DTAF-labelled ALG was separated from free DTAF by extensive dialysis against 
water. The solvent of the final solution was evaporated in the rotary evaporator, during 1 
hour, approximately. Then, the obtained material was dissolved in 14mL of NaCl (0.15M) 
and distributed in several 1mL eppendorfs (the final concentration in solution was 1mg/mL). 
These tubes were kept at -20ºC, covered with foil [103].   
 To prepare the RITC-labeled CHI solution, 20mg of RITC (1mg/mL in methanol) 
were added to 20mL of CHI (1%)(w/v) and the mixture was allowed to react during three 
hours, at room temperature, protected from the light and with gentle stirring. After, NaOH 
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(0.5M) was added to increase the pH to 10 (pH=10.56) in order to obtain a precipitate. 
Then, the solution was transferred to eppendorfs and centrifuged during 15 minutes at 
15000g; the supernatant was removed and the pellet was washed with distilled water, and 
centrifuged again. This procedure was repeated until obtaining no fluorescence in the 
supernatant (6-7 centrifugations were done). After the centrifugations, the pellet was 
dissolved in 20mL of acetic acid (0.1M) and submitted to a dialysis process (against water, 
during three days, protected from the light; the water was changed daily). The dialysis used 
a cellulose membrane previously treated according to the manufacturer instructions (a 
solution of sodium bicarbonate 2% and EDTA 1mM was used; the membrane was put 
inside a reservoir with a high volume of this solution, during 30 minutes, at 80ºC). After the 
dialysis, the solution was dried in a rotary evaporator and dissolved in 40mL of a solution 
containing acetic acid (0.1M) and NaCl (0.15M) [104, 105]. The final solution had a 
concentration of 5mg/mL and it was kept at 4ºC, distributed in eppendorfs. To use this 
solution for cell encapsulation, it was necessary to dilute it to 1mg/mL.  
 
2.5 Cell encapsulation   
 First, cells were trypsinised (during 10 minutes) from the cell culture plates where 
they were growing and counted in the inverted optical microscope using a 
hematocytometer (dilution 3:1, when necessary). After counting, depending on the amount 
of cells needed in the experiment, the suitable volume of cell suspension was transferred to 
an eppendorf, the suspension was centrifuged, cells were washed with a NaCl solution 
(0.15M) and centrifuged again (2500rpm, 8 min, 25°C).  
Different pairs of polymers were used in the LbL method to encapsulate cells 
(CHI/ALG, PAH/ALG and PAH/HA). Previous fluorescent labelled alginate and chitosan 
were also used, depending on the experiments. After centrifugation, the cells were re-
suspended with 500μL of the solution containing the cationic polymer and left during a 
certain period of time (depending on the experiment) at 37ºC. After, the cell suspension 
was centrifuged (5 min, at 2500rpm) and the remaining pellet was washed with a solution 
of NaCl (0.15M) to remove the excess of un-adsorbed polyelectrolyte. The anionic polymer 
was adsorbed in the same manner (but the centrifugation speed was increased to 5000rpm 
(since the alginate solution presented some viscosity). This process was repeated until a 
layering scheme of cells/(P+/P-)n, was produced, where n represented the number of 
bilayers and P+ and P-  the cationic polymer and anionic polymer, respectively. At the end, 
the encapsulated cells were re-suspended in 500μL of NaCl 0.15M or 500μL of cell culture 
medium and observed at the inverted fluorescence microscope or analysed for cell viability, 
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respectively. Another counting was done using the hematocytometer to confirm the number 
of cells (encapsulated cells) in solution. 
 In part of the experiments, collagen was also used as a first conditioning layer 
before deposition of the first layer of the cationic polyelectrolyte. The idea behind collagen 
use was that the cell-matrix interactions could be mimetized (supplying survival signals), 
thus improving cell viability [106]. 
 
2.6   Observation of the encapsulated cells in the inverted 
fluorescence microscope 
Cells were observed in the inverted fluorescence microscope to verify if single cell 
encapsulation was achieved. As a tool to observe the contour of the polyelectrolyte layers 
surrounding the cells, DTAF-labelled alginate was used as the anionic polymer. DTAF 
(fluorescein dichlorotriazine) is a “green” dye which reacts with amino groups, but also with 
thiol groups and hydroxyl groups present in polysaccharides (covalent links) or other 
alcohols in aqueous solution at a pH above 9 (Figure 13). DTAF presents an λAbsorption = 
492nm and λEmission = 517 nm [107].  
 
 
Figure 13 - DTAF structure [107]. 
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As an alternative, RITC-labelled chitosan was used as the cationic polymer. RITC 
(rhodamine-B-isothiocyanate) is a “red” dye (Figure 14). 
The synthesis of RITC-labelled chitosan was based on the reaction between the 
isothiocyanate group of RITC and the primary amino groups of chitosan. The RITC 
compound presents an λexcitation = 570 nm and λEmission = 595 nm [108, 109].  
 
 
 
Figure 14 - RITC structure. 
 
On the other hand, the cell nucleus was stained with DAPI. DAPI (4',6-diamidino-2-
phenylindole) molecule is a low molecular weight fluorescent dye (Figure 15), which has 
the capacity to penetrate easily in the polyelectrolyte capsule and in the cell membrane and 
link to the nuclear and mitochondrial DNA. It is the most famous dye used in experiments 
involving cells. When it is bounded to a double-stranded DNA, DAPI has its absorption at 
358 nm (ultraviolet) and its emission at 461 nm (blue) (Figure 16) [12]. 
 
 
Figure 15 - Left: DAPI structure; Right: DAPI bounded to DNA. 
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Figure 16 - Fluorescence excitation and emission profiles of DAPI bound to dsDNA [110]. 
 
 
The use of this dye is very advantageous to verify the cell structure preservation, 
which means that the intact cells will exhibit areas with a well-defined bright fluorescent, 
while the corrupt ones will show a diffuse blue emission [12]. 
A stock solution 5mg/mL of DAPI was prepared in distilled water and kept at 4ºC, 
protected from light. 1µL of a 2500x dilution of the stock DAPI solution was added to the 
500μL of medium used in the wells of 48 wells culture plates containing the encapsulated 
cells. After 10 minutes at room temperature, the mixture was centrifuged and 500μL of 
NaCl solution (0.15M) was added for washing and re-suspension. Finally, the sample was 
observed in the inverted fluorescence microscope (λabsorption = 358 nm; λemission = 461 nm 
[12]. 
  
2.7   Evaluation of the viability of the encapsulated cells  
The viability of the encapsulated cells was evaluated by qualitative (Live/Dead 
assay) and quantitative means (the MTT reduction assay and the Resazurin reduction 
assay).  The viability tests done with the encapsulated cells were performed after 0h, 1day 
and 3 days in culture; in some cases after 7 days.   
 
2.7.1 Live/Dead Assay 
 In this method, two different dyes are used: fluorescein diacetate (FDA) and 
propidium iodide (PI) (Figure 17).  
The first dye identifies the living cells and the other one identifies the dead ones. 
The FDA (nonpolar ester) passes through the cell membrane and is cleavaged by 
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intracellular esterases. This cleavage results in the fluorescent compound “fluorescein”, 
which emits in the green range, when the stained cells are metabolically active. Fluorescein 
(which is a polar compound) stays accumulated inside the cell, exhibiting green 
fluorescence, when irradiated with blue light in a fluorescence microscope (Figure 18) [111, 
112]. 
The PI passes through damaged cell membranes, having the capacity to intercalate 
with the DNA and RNA, creating a bright red fluorescent complex, visualized in the nuclei 
of dead cells, when seen in the fluorescence microscope. If the cells are alive, this dye is 
excluded by their healthy membrane. The intensity of the red fluorescence observed can 
depend on the degree of nuclear membrane disruption (Figure 18). The PI and other dyes 
(like trypan blue), are considered DNA-intercalating dyes, and they estimate cell membrane 
transport properties [111, 112]. 
 
Figure 17 - FDA (on the left)) and PI (on the right) structures. 
 
 
Figure 18 - Confocal images of rat lung slice co-stained with the LIVE/DEAD® viability/cytotoxicity assay kit for 
animal cells [113]. 
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For the Live/Dead assay, 1µL of FDA and 10µL of PI were added to the 
encapsulated cells present in 500μL of NaCl 0.15M. After 10 minutes, the mixture was 
centrifuged and the pellet was washed twice with NaCl 0.15M. The final sample was 
observed in the inverted fluorescence microscope. 
 
2.7.2 MTT reduction assay 
The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) method also 
informs about the metabolic state of the cells. This dye presents a yellow colour and, if the 
cells are alive, there will be a reduction reaction by the mitochondrial reductases present 
inside the cells, resulting in a solid compound with purple colour, called formazan (Figure 
19) (λ = 570nm) [6]. The obtained compound, being solid, must be dissolved in a suitable 
solvent, for instance, DMSO (dimethyl sulfoxide). After the dissolution, the amount of the 
formazan produced can be determined with a spectrophotometer [66]. 
 
 
Figure 19 - MTT is reduced to formazan (s) by a mitochondrial reductase. 
 
In the experiments, the MTT reagent was added directly to each well (50µL for 
500µL of cell culture medium containing the encapsulated cells). After 3-4 hours, cells were 
disrupted with DMSO (dimethyl sulfoxide) and absorbance was measured using a 
microplate reader at 570nm (100µL of each solution was added to a well of a transparent 
96 wells culture plate).  
 
2.7.3 Resazurin reduction assay 
This method is a fluorometric method for estimating the number of viable cells. It 
uses the indicator dye Resazurin to measure the metabolic capacity of cells. It is an 
indicator of cell viability [114]. 
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If the cells are viable, they become able to reduce resazurin into resorufin (as a 
result of the action of several different redox enzymes), which is highly fluorescent (Figure 
20). The nonviable cells lose their metabolic capacity, so they do not reduce the indicator 
dye, and because of that, there is not a fluorescent signal. Resazurin presents a dark blue 
color and has a little intrinsic fluorescence until it is reduced to resorufin, which is pink and 
highly fluorescent (λExcitation = 579 nm, λEmission = 584nm) [114]. 
 
 
Figure 20 - Conversion of resazurin to resorufin by metabolically active cells results in the generation of a 
fluorescent product [114]. 
 
 Under most experimental conditions, the fluorescent signal from resazurin is 
proportional to the number of viable cells. There is a linear relationship between cell 
number and fluorescence. The linear range and lower limit of detection are dependent on 
the cell type and the ability to reduce resazurin. The procedure is shown below (Figure 21). 
Resazurin is added directly to each well, then the plates are incubated at 37°C to allow 
cells to convert resazurin to resorufin, and the fluorescent signal is measured in a 
spectrophotometer [114]. 
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Figure 21 - The CellTiter-Blue® Cell Viability Assay protocol [114]. 
 
In the experiments, 10µL of resazurin solution (prepared at a concentration of 0.1% 
in PBS) was added per 100µL of medium present in the well containing the encapsulated 
cells. Then, the plates were incubated at 37°C, during 3-4 hours, to allow cells to convert 
resazurin to resorufin. The fluorescent signal was measured in a microplate reader (100µL 
of each solution was added to a well of an opaque 96 wells culture plate).  
   
2.8   Cells cultured over the 2D-surface of the cell culture dish but 
under polyelectrolyte layers – evaluation of cell viability     
Only human MSCs were used in these studies, as well as the pair of 
polyelectrolytes PAH/ALG. Cells were seeded in the surface of cell culture wells at the 
desired cell density. After 24h in culture, the cell culture medium was removed and a 
solution containing the cationic polyelectrolyte was putted in contact with cells during 10 
minutes, at 37ºC. Then, the culture was washed twice with 0.15M NaCl and the process 
was repeated with the anionic polyelectrolyte. This process was repeated until a layering 
scheme of cells/(P+/P-)n, was produced, where n represented the number of bilayers and P+ 
and P-  the cationic polymer and anionic polymer, respectively. For the control, 0.15M NaCl 
without polyelectrolytes was used throughout the process.  
Cell viability was determined after 0h, 1 day, 3 days and, for certain cases, 7 days in 
culture. Both the Live/Dead assay and the Resazurin reduction assay were used, according 
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to the procedures above described. In the Resazurin test, the solution of resazurin is added 
at each time point. In some experiments, resazurin was only added at 0h, but resorufin 
florescence was still measured at different time points (as the low/absence of cell viability 
could be associated with difficulties in the diffusion of resazurin throughout the 
polyelectrolyte layers, this assay allowed us to put aside this possibility). 
 
2.9   Evaluation of the polymers cytotoxicity    
The low/absence of cell viability leaded us to make a systematic study (dose-effect 
study) of the effect of polyelectrolyte concentration on cell viability. This study was done 
with human MSCs and using the Live/Dead assay and the Resazurin reduction assay 
(along 0h, 1 day, 4 days and 7 days). The concentrations investigated were: 500μg/mL, 
100μg/mL, 50μg/mL, 10μg/mL, 1μg/mL, 500ng/mL, 250ng/mL and 50ng/mL (dilution from a 
‘mother solution’ of 1mg/ml). The assays were done for PAH, CHI and ALG. 
Cells were seeded at the desired concentration in cell culture plates and let adhere 
and growth during 24h before contact with the polyelectrolyte solution. For the Resazurin 
method, 96 wells culture plates (for adherent cells), 20μL of polymer solution/well and 
3.0x104 cells/cm2 were used; washing with NaCl (0.15M) was done 3 times after a contact 
time of 10 minutes between the polymer and the cells. After, 10μL of resazurin solution was 
added per well and, 4h later, resorufin fluorescence was measured. The Live/Dead Assay 
was performed in 48 wells culture plates (for adherent cells), adding 200μL of polymer 
solution per well and using a cell density of 1.8x104 cells/cm2.  Again, washing with NaCl 
(0.15M) was done 3 times after a contact time of 10 minutes between the polymer and the 
cells. In the assay, 1μL of FDA and 10μL of PI solutions were added to 500μL of medium. 
The final sample was observed in the inverted fluorescence microscope. 
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CHAPTER 3 – RESULTS AND DISCUSSION 
 
3.1  Establishment of the best experimental conditions to obtain 
the encapsulation of single cells    
The first part of the work consisted in the establishment of adequate experimental 
conditions to achieve the encapsulation of individual cells. The general procedure used for 
cell encapsulation was based on the Layer-by-Layer technique and is schematised in 
Figure 22. Mesenchymal stem cells and the fibroblastic line NIH 3T3 were used in these 
initial experiments. The pair of electrolytes chosen was chitosan and alginate and, based 
on the work of Xia Tao and co-workers [8], solutions of 1mg/mL were used in the LbL 
process. To visualize the capsules in the fluorescence microscope, DTAF-labelled alginate 
(which emits in the green area of the spectrum) was used or, in alternative, RITC-labelled 
chitosan (which emits in the red area of the spectrum).  The nuclei of the cells were 
visualized in the samples by staining them with the fluorescent dye DAPI (which emits in 
the blue area of the spectrum). The DAPI, being a low-molecular-weight dye, had the 
capacity to pass through the capsule easily, and to bind to the nuclear and mitochondrial 
DNA present in the cell [12]. The objective was to have only one cell inside one capsule. 
Experimental variables such as (i) the time of contact between polyelectrolytes and 
cells, (ii) the way cells were washed between polyelectrolytes adsorption, (iii) cell 
concentration and (iv) the method of re-suspending and stirring the cells after centrifugation 
were studied.  
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Figure 22 - General procedure used in the encapsulation of cells. 
 
The tested times of contact between cells and polyelectrolytes were 5 minutes and 
10 minutes but no influence was noted in the obtainment of encapsulated single cells. 
Based on these results, a 10 minutes contact time was chosen to be used in all other 
experiments. 
The washing step just after polyelectrolyte adsorption is a normal step in the LbL 
technique [6, 12, 115]. This washing is used to remove the excess of polyelectrolyte (not 
absorbed) and will, in principle, improve the observation of the samples in the 
Fluorescence Microscope by minimizing blur. 
In the present work, three procedures were tested: (i) cells were not washed 
between polyelectrolytes deposition; (ii) washing was done with a solution of NaCl at 
0.15M; and (iii) washing was done with Hank’s Balanced Salt Solution. NaCl at 0.15M was 
used because it is a very simple solution having an isotonic concentration [66]. HBSS was 
used based on the work of Verrabadran and co-workers [6]. The results obtained with 
these three approaches were similar but, anyway, it was decided to keep the step of 
washing with NaCl 0.15M between polyelectrolytes deposition.   
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Figure 23 illustrates the type of images obtained with these systems using 
fluorescence microscopy. Here, rat MSCs were encapsulated within 1 bilayer of CHI/ALG-
DTAF. The step of washing between polyelectrolytes adsorption was done with NaCl 
0.15M and the time of contact between the cells and the polyelectrolyte solutions was 10 
minutes. The blue fluorescence signals emitted by cell nuclei are clearly seen and their co-
localization with the green fluorescence signals arising from the polyelectrolyte capsules is 
evident. 
 
 
 
 
 
Figure 23 - Images obtained in the Fluorescence Microscope. Rat MSCs were encapsulated within 1 bilayer of 
CHI/ALG-DTAF; A: Green fluorescence from ALG-DTAF; B: Blue fluorescence from DAPI; C: merged images of 
both A, B. The nuclei (in blue) are inside the capsules (green). 
These first set of experiments were done without measuring the number of cells in 
solution. As many aggregates were noticed in the observed samples, we hypothesized that 
maybe this problem could be related with a high cell concentration. An experiment was 
then done using different amounts of cells in the encapsulation process (Figure 24). The 
initial quantity of cells placed in the eppendorfs was 1.5x105, 3.0x105 and 7.5x105 cells. At 
the end of the encapsulation process, as the capsules containing the cells were re-
suspended in 500μL of NaCl 0.15M, the encapsulated cell concentrations were 
3.0x105cells/mL, 6.0x105cells/mL and 15.0x105cells/mL, respectively. Results showed that 
capsules aggregation increased with the number of initial cells used. 
(A) 
(C) 
(A)  (B) 
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Figure 24 - Images of NIH 3T3 cells were encapsulated within 1 bilayer of CHI/ALG-DTAF. The images were 
obtained in the Fluorescence Microscope for an initial number of cells of A: 1.5x105, B: 3.0x105 and C: 7.5x105. 
Green fluorescence from ALG-DTAF is observed. The step of washing between polyelectrolytes adsorption was 
done with NaCl 0.15M and the time of contact between the cells and the polyelectrolyte solutions was 10 min. 
 
However, the mentioned aggregation problem was not completely solved by 
decreasing the cell number. In fact, Veerabadran and co-workers [6] used a much higher 
starting quantity of cells (5x106 cells in 1mL) in their encapsulation studies and obtained the 
capsules more or less isolated. It must be said, however, that the experimental procedure 
used by Veerabadran and co-workers is not presented in detail in their publication, not 
allowing a full comparison of the results. For instance, they do not refer how much volume 
of polyelectrolyte solution was added to the cell suspension.  
Therefore, believing that the cell concentration was not the unique factor affecting 
the aggregation of the encapsulated cells, several experiments were done to evaluate the 
effect of the type of stirring used during the cell re-suspension steps inherent to the 
process. Table 3 resumes the results obtained in experiments done with initial cell numbers 
of 1.5x105 and 5.0x105 and by encapsulating NIH 3T3 cells within 1 and 2 bilayers of 
polyelectrolytes. Stirring was performed by simply passing the cell suspension through the 
small tip of a micropipette several times, or by using a vortex mixer, an orbital mixer or a 
spinning magnet inside the tube containing the cell suspension. Moderate levels of cell 
aggregation were obtained with the use of a micropipette or the vortex mixer. In all other 
situations, the level of cell aggregation was high. Although the use of a vortex mixer 
seemed to be one of the best strategies to obtain separated encapsulated cells, due to 
concerns related with cell viability (cells could not resist to the strong forces generated 
during vortexing), the micropipette was used for stirring in all the following experiments. 
 
 
 
 
 
(A)  (B)  (C) 
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Table 3 - Effect of the type of stirring used in the cell re-suspension steps on cell aggregation (+++, ++ and + 
represents high, moderate and low levels of cell aggregation, respectively). 
 
Micropipette 
(during ‘min, 
until 10’) 
Vortex (10s) 
Orbital mixer 
(37ºC, 300rpm) 
Spinning 
magnet 
(10’, 750rpm) 
1.5x105cells 
(3x105 cells/mL) 
1 bilayer 
++ ++ * * 
5.0x105cells 
(1x106 cells/mL) 
2 bilayers 
++ * +++ +++ 
* Not studied 
 
3.2 Evaluation of the viability of cells encapsulated within 
CHI/ALG bilayers 
After knowing that it was possible to obtain single encapsulated cells through the 
LbL technique, the next step was to verify if cells remained viable inside the capsules.  
 The first set of experiments used NIH 3T3 cells encapsulated within 1 and 2 bilayers 
consisting of CHI and ALG. A low cell concentration was used to minimize aggregation 
(4x104 cells in each well of a 48-well culture dish) and cell viability was studied using the 
MTT test. Cell viability just after the cell encapsulation process (at 0h of cell culture) was 
0% in relation to the values obtained with non-encapsulated cells. The treatment applied to 
non-encapsulated cells was equal to the one applied to the encapsulated cells, except that 
no polymers were present in the solutions. Thinking that, for some reason, the MTT test 
was not suitable to evaluate the metabolic activity of the encapsulated cells, two other cell 
viability tests were used: the resazurin reduction assay and the Live/Dead assay. Figure 25 
shows the results obtained with the first method. Cell viability was extremely low at the 
beginning of cell culture (0h) and, after 3 days, decreased to 0%.  
The Live/Dead assay results were in accordance with these findings. As can be 
seen in Figure 26, NIH 3T3 cells appear red under the fluorescence microscope due to 
propidium iodide incorporation, revealing that cells were damaged (not viable). Results are 
shown for cell viability analysis at 0h of cell culture but identical images could be seen after 
1 day in culture (data not shown). These experiments were also performed with hMSCs. 
Results have also shown the lack of cell viability since the beginning of the cell culture. 
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Figure 25 – Evaluation of the metabolic activity of NIH 3T3 cells encapsulated within 1 and 2 bilayers of 
CHI/ALG using the resazurin reduction assay after 0h (A) and 3 days (B) of cell culture. 
  
         
Figure 26 – Evaluation of the viability of NIH 3T3 cells encapsulated within 1 (A) and 2 bilayers (B) of CHI/ALG 
using the Live/Dead assay at the beginning of cell culture (0h). Dead cells are red under the fluorescence 
microscope. 
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3.3 Evaluation of the viability of cells encapsulated within 
PAH/ALG bilayers 
As the obtained results were not satisfactory for the pair of electrolytes CHI/ALG 
(cell viability was null), it was decided to change CHI by another cationic polyelectrolyte. In 
fact, chitosan was not soluble at the physiological pH and had to be dissolved in a solution 
containing acetic acid (pH=4.1). 
So, maybe the cells were not able to support the low pH of the chitosan solution and 
died. 
Poly(allylamine hydrochloride) was then chosen as the new cationic polyelectrolyte 
for cell encapsulation through the LbL technique. For starting, the obtainment of single 
encapsulated cells with the pair of electrolytes PAH/ALG was checked using hMSCs. 
Figure 27 (A) clearly shows that the blue fluorescence signals emitted by cell nuclei are co-
localized with the green fluorescence signals arising from the polyelectrolyte capsules. So, 
also in this situation, single cell encapsulation was obtained. 
In order to improve cell viability inside the capsules made of PAH/ALG, another 
strategy was studied. Before the formation of the PAH/ALG layer, cells were putted in 
contact with a solution containing collagen type I. Collagen type I is a negative polymer but 
can establish linkages with the cell surface through specific receptors (such as the integrins 
which exist at the MSCs surface) [116]. The objective was to allow cells to closely interact 
with a matrix protein, providing them the necessary cell survival signals which could help 
maintain their viability. Indeed, the animal cells used in the present work are adherent cells 
(anchorage dependent cells) and the lost of cell-matrix interactions inherent to the 
procedure applied in the LbL technique is an important issue which cannot be forgotten. By 
loosing cell-matrix interactions, cells can enter apoptosis and lose their viability.  
Although not concerned with single cell encapsulation, an interesting work of 
Golnaz Karoubi and co-workers [115] has shown that capsules supplemented with matrix 
proteins (fibronectin and fibrinogen) re-introduced the cell-matrix interactions and, in 
consequence, provided the necessary signals to rescue the cells to suffer apoptosis, 
increasing therefore their viability. Collagen has very important roles in human body, being 
the major constituents of several types of specialized extracellular matrices. Studies of 
collagen-binding integrins in several in vitro assays show that they participate in cell 
migration, cell adhesion, control of collagen synthesis, matrix metalloproteinase (MMP) 
synthesis, and influence some processes such as cell differentiation, cell proliferation, 
angiogenesis, between others [115, 116]. 
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Collagen is known to be a promising material, thus, it has been applied in many 
applications in the tissue engineering area, due to its excellent biocompatibility and 
biodegradability [117, 118]. 
The use of an inner collagen layer, in close contact with the MSC surface, did not 
had influence on the obtainment of single encapsulated cells, as can be seen in Figure 27 
(B).  
        
Figure 27 - Images obtained in the Fluorescence Microscope. hMSCs were encapsulated within 1 bilayer  of 
PAH/ALG-DTAF without (A) and with an inner collagen layer (B). The step of washing between polyelectrolytes 
adsorption was done with NaCl 0.15M and the time of contact between the cells and the polyelectrolyte 
solutions was 10 min. Green fluorescence is due to ALG-DTAF and blue fluorescence to DAPI (the merged 
images are shown). The nuclei (in blue) are inside the capsules (green). 
 
The viability studies using these new encapsulated cells (PAH/ALG and 
Collagen/PAH/ALG) and the Live/Dead assay were more promising. As can be observed in 
Figure 28, the hMSCs appeared red under the fluorescence microscope due to propidium 
iodide incorporation only at the beginning of cell culture (0h); after that (1 day and 3 days in 
culture), the cells seemed to recuperate and appeared green due to fluorescein diacetate 
intake, revealing that cells were metabolic active (viable). The presence of collagen did not 
have an influence on these results. However, it was noticed that the presence of collagen 
in the capsules turned the manipulation of the pellets easier during the LbL experimental 
process.  
  
(A)  (B)
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Figure 28 - Evaluation of the viability of hMSCs cells encapsulated within 1 bilayer of PAH/ALG (A) and 1 
bilayer of collagen/PAH/ALG (B) using the Live/Dead assay at several cell culture times (0h, 1 day and 3 days). 
Dead cells are red and live cells are green under the fluorescence microscope. 
 
Cell viability was also evaluated through the resazurin reduction assay for cells 
encapsulated within PAH/ALG. The viability of the encapsulated cells at the beginning of 
the cell culture (0h) was approximately zero. To put aside the possibility of existing diffusion 
problems preventing resazurin to reach the cells, in a first experiment, it was decided to 
measure resorufin fluorescence 3h (the normal period, as described in the “Materials and 
Methods” chapter), 6h and 24h after resazurin addition to the cell culture medium. Thus, 
resazurin was only added once in the cell culture medium and enough time was given for 
the molecules to reach the interior of the cells. Results are summarized in Table 4 and 
show that resazurin diffusion through the polyelectrolyte layers was not a problem. Instead, 
it must be the encapsulation process that affects the cell metabolic activity. In opposition to 
what was expected, the results of the resazurin reduction assay were not in agreement with 
those obtained through the Live/Dead assay for which cells looked viable after 1 day and 3 
days in culture. 
1 day 
1 day 
3 days 
3 days 
0h 
0h 
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 To enhance the probability of cell survival, it was also decided to perform an 
experiment with increasing concentrations of fetal bovine serum (FBS) in the cell culture 
medium. The FBS contains several growth factors and survival signals which could 
improve cell survival [66]. 
However, experiments done with 20% and 40% of FBS in cell culture medium 
haven’t conducted to different results in terms of cell viability. 
 
Table 4 - Cell viability results using the resazurin reduction assay. hMSCs were encapsulated within 1 bilayer of 
PAH/ALG polyelectrolytes and resazurin was added only at 0h. Resorufin fluorescence was measured after 3h, 
6h and 24h of cell culture. Results are expressed as a percentage of the control. 
 Control   
Encapsulated cells  
(1 bilayer)  
After 3h 100.0±0 1.0±1.9 
After 6h 100.0±0 2.0±1.6 
After 24h 100.0±0 0±1.1 
 
 
3.4 Evaluation of the viability of cells encapsulated within PAH/HA 
bilayers 
Another attempt was made for obtaining single encapsulated viable cells, this time 
changing alginate by hyaluronic acid. hMSCs were, then, encapsulated in the interior of 1 
or 2 bilayers consisting of PAH/HA. Cell viability studies were done using a percentage of 
serum in the cell culture medium of 20% (v/v) or 40% (v/v).  
Based on the resazurin reduction assay, at 0h, cell viability was about 22% and 29% of 
that present in the control for cells encapsulated within 1 and 2 bilayers of PAH/HA, 
respectively. After 1 day, there were no signals of cell metabolic activity. When the 
percentage of serum was raised to 40%, at day 0, those values increased to 32% and 44%, 
respectively, but also decreased to zero after 1 day. These results are exposed in Figure 
29. 
Surprisingly, the results obtained with the Live/Dead assay showed dead cells at 0h 
and live cells for later times (Figure 30). Again, this two cell viability evaluation methods 
seem to not correlate with each other. 
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Figure 29 - Evaluation of the metabolic activity of hMSCs encapsulated within 1 and 2 bilayers of PAH/HA using 
the resazurin reduction assay after 0h and 1 day in culture. Experiments were done with a percentage of 20% 
(A) and 40% (B) of FBS in the cell culture medium. 
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Figure 30 - Evaluation of the viability of hMSCs encapsulated within 1 (A) and 2 bilayers (B) of PAH/HA using 
the Live/Dead assay after 0h, 1 day and 3 days in culture. Experiments were done with a percentage of 20% of 
FBS in the cell culture medium. 
 
3.5 Evaluation of the viability of cells cultured over the 2D-surface 
of the cell culture dish but under polyelectrolyte layers  
 This last experiment (using PAH/HA systems) showed that it was possible to 
increase the viability of cells encapsulated inside polyelectrolyte layers by playing with the 
type of polyelectrolytes used in the LbL procedure and, also, by providing cells with survival 
factors such as those present in serum. However, the improvement verified with the pair of 
polyelectrolytes PAH/HA and using 40% of FBS in the cell culture medium was not brilliant. 
So, instead of further exploring the PAH/HA systems, it was decided to try to 
understand why it was so difficult to maintain cell viability inside the polyelectrolyte 
capsules. So, it was hypothesized that as NIH 3T3 cells and MSCs are adherent cells, they 
would always need a substrate to attach in order to survive and that the lack of viability was 
mainly related with the fact that cells were cultured in suspension.  According to this idea, 
cells cultured attached to the surface of a cell culture dish and coated in their top with 
layers of polyelectrolytes (also using the LbL method) would be able to survive.  
0h 1 day 3 days 
0h 1 day 3 days 
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 The next step of this Master thesis was, then, to culture hMSCs attached to the 
surface of cell culture plates (a monolayer of cells) but having layers of the polyelectrolyte 
pair PAH/ALG deposited over them (see Figure 31 (A, B)). Cells were seeded at a 
concentration of 2.6x104cell/cm2 and cultured during 7 days. Experiments were done by 
depositing 1, 2 and 4 bilayers of polyelectrolytes over the cells. The experimental 
conditions used for encapsulation of single cells were maintained, namely, the time of 
contact between cells and the polyelectrolyte solutions was 10 minutes and the 
concentration of the polyelectrolyte solutions was 1mg/mL). Cell viability was assessed 
using the resazurin reduction assay and the Live/Dead assay.  
 Surprisingly, cell viability was also absent in these “two-dimensional” experiments 
where hMSCS were cultured like in a sandwich, between the surface of the cell culture dish 
and the polyelectrolyte layers. Results can be seen in Figure 32,  
Figure 33 and Figure 34. 
The data obtained from the resazurin reduction assay is shown only for 0h and 1 
day of cell culture (for the other time points the results were identical). An important 
observation is that, by looking to the decreasing values of the metabolic activity associated 
with the different control experiments when the number of bilayers is increased, one can 
see that cell viability was strongly affected by the LbL process itself (maybe by the time that 
cells spent out the incubator). It must be reminded that the experiments done with different 
layers of polyelectrolytes had different controls (each control passed through all the 
procedures suffered by the sample except that no polymers were added to the solutions). 
 Figure 35 shows the morphology of hMSCs (bright field images) cultured with 2 and 
4 bilayers of polyelectrolytes over them and after 7 days in culture. Cells presented an 
irregular morphology, characteristic of damaged cells.   
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Figure 31 - Experimental procedure used in the assays (A); Scheme showing cells adherent to the plastic 
surface of the cell culture dish and having layers of polyelectrolytes over them (B); 
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Figure 32 - Evaluation of the metabolic activity of hMSCs cultured under 1, 2 and 4 bilayers of PAH/ALG using 
the resazurin reduction assay after 0h (A) and 1 day (B) in culture. 
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A For 2 layers: 
 
 
 
 
 
B For 4 layers: 
 
 
 
 
 
 
 
Figure 33 - Evaluation of the viability of hMSCs cultured under 1 (A) and 2 (B) bilayers of PAH/ALG using the 
Live/Dead assay after 0h, 1 day, 3 days and 7 days in culture. Dead cells are red and live cells are green under 
the fluorescence microscope. 
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C For 8 layers: 
 
 
 
 
 
Figure 34 - Evaluation of the viability of hMSCs cultured under 4 (C) bilayers of PAH/ALG using the Live/Dead 
assay after 0h, 1 day, 3 days and 7 days in culture. Dead cells are red and live cells are green under the 
fluorescence microscope. 
 
Figure 35 - Bright field images of cells cultured under 2 (A) and 4 (B) bilayers of PAH/ALG. The skinny arrows 
exemplify the nuclei of the cells and thick ones the extracellular membrane. 
 
After this experiment which was also unsuccessful in terms of cell viability, the 
possibility that high (cytotoxic) concentrations of polymers were being used was raised. In 
fact, as already referred, 1mg/mL polyelectrolyte solutions were being applied based on the 
concentrations used by other authors also working with MSCs [6]. 
0h 1 day 
3 days 7 days 
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As cationic polymers are usually much more cytotoxic than anionic ones [86, 119], 
another experiment was performed with only 1 bilayer of polyelectrolytes over the cells and 
using lower concentrations of PAH in solution (0.1mg/mL and 0.5mg/mL); on the other 
hand, the amount of alginate that will adsorb at the cell surface will be dependent on the 
quantity of cationic polymer initially adsorbed. Therefore, it was reported that the ‘density’ 
of the polyelectrolyte bilayer adsorbed to the cells can be controlled by varying just the 
concentration of PAH itself [68]. The concentration of alginate was maintained. The results 
are shown in Table 5. Also in this case, cell viability was severely affected.  
 
Table 5 - Evaluation of the metabolic activity of hMSCs cultured under 1 bilayer of PAH/ALG using the resazurin 
reduction assay after 0h, 1 day, 3 days and 7 days in culture. PAH concentrations in solution of 0.1mg/mL and 
0.5mg/mL were studied. 
 Control 100µg/mL 500µg/mL 
0h 100.0±0 0±3.6 0±2.5 
1 day 100.0±0 6.0±2 5.0±2 
3 days 100.0±0 3.0±0.3 2.6±0.4 
7 days 100.0±0 4.0±0 4.5±0.6 
 
 
3.6 Evaluation of polyelectrolyte cytotoxicity  
 After all the experiments done before, it was evident that a systematic study would 
have to be performed to evaluate the effect of polyelectrolyte concentration on cytotoxicity. 
A set of experiments was than programmed for individually testing the cytotoxicity of 
CHI, PAH and ALG using hMSCs in culture. As explained in more detailed in the Materials 
and Methods chapter, cells were seeded in cell culture plates and, 24h later, they were 
covered with solutions containing the polyelectrolyte under study at the desired 
concentration during 10 minutes. After, the cultures were washed with a saline solution and 
left to growth until 7 days. The dose-response effects were quantitatively studied using the 
resazurin reduction assay and are presented in Table 6 and Figure 36 in respect to control 
values. The Live/Dead assay was used as a qualitative mean to evaluate the effect of the 
polyelectrolyte concentration on cell viability. These results are shown in Figure 37 to 
Figure 39.  
 The cell metabolic activity results depend on the period of time that cells remain in 
culture. Just after the end of polyelectrolyte exposure (0h), the cell metabolic activity 
presents the lowest values in respect to the control values. After culturing cells for some 
time, cells seem to adapt to the new situation and recover from the suffered injury, 
proliferating in culture and raising their metabolic activity.  
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In general, the results from the resazurin reduction assay show that PAH is much 
more cytotoxic than CHI and ALG. As expected, ALG is the less cytotoxic polyelectrolyte. 
As example, for a dose of 500µg/mL of polyelectrolyte, at 0h, cell viability was 0%, 
53% and 20% of the control values for, respectively, PAH, ALG and CHI. This information 
is very important to understand the lack of viability verified for the encapsulated cells. In 
fact, the LbL method applied to encapsulate the cells used polyelectrolyte concentrations of 
1mg/mL, a value which corresponds to severe cytotoxic effects. Furthermore, the 
encapsulated cells are simultaneously putted in contact with 2 kinds of polyelectrolytes 
and, thus, the cytotoxic effects can be even more potentiated. So, future work in these 
systems should have this in consideration and much lower polyelectrolyte concentrations 
must be used. 
 The results from the Live/Dead assay correlate well with the results obtained 
through the resazurin reduction assay. However, at 0h, for the PAH at the highest 
concentrations, cells should look red (since the percentage of metabolic activity obtained in 
the resazurin reduction assay was near zero) but appear green under the fluorescence 
microscope. For the CHI, the contrary happens: cells should look green (since low but 
positive values were obtained for the percentage of metabolic activity using the resazurin 
reduction assay) but appear red under the fluorescence microscope. This is in line with 
some of the results obtained with the encapsulated cells for which the cell viability results 
assessed by the two methods were frequently in disagreement.  
Indeed, the two methods are often used to evaluate cell viability but they are based 
in different principles: the resazurin method is dependent on the activity of intracellular 
enzymes (metabolic activity) and the Live/Dead assay is dependent on the extension of cell 
membrane damage (PI, being hydrophilic, is excluded from the membrane of viable cells, 
whereas FDA, being non-polar, can pass through them). A possible explanation for the 
disagreement between these two methods (which mainly occurs at the beginning of cell 
culture, just after the end of cell/polyelectrolyte contact) is that cell membrane deterioration 
does not occur exactly at the same time as enzymes lose their activity. So, the resazurin 
reduction assay correlates well with the Live/Dead assay only for later times after 
polyelectrolyte exposure.  
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Table 6 - Effect of polyelectrolyte concentration on hMSCs viability (“dose-effect” studies) obtained through the resazurin reduction assay. Results are shown as a percentage 
of the control values. Cell viability was analysed along 7 days. 
 
  PAH ALG CHI 
Polymer 0h 1 day 4 days 7 days 0h 1 day 4 days 7 days 0h 1 day 4 days 7 days 
500µg/mL 0.3±0 1.9±1 0±3 0±2 53.3±8 59.8±7 105.5±13 89.9±4 20.4±2 19.2±7 24.9±28 52.5±20 
100µg/mL 0.4±1 2.2±1 0±1 1.1±2 47.0±3 55.7±4 95.9±7 84.6±3 53.0±3 38.8±10 15.3±18 40.8±24 
50µg/mL 2.5±1 2.8±1 6.8±6 37.3±19 52.0±10 60.1±6 91.3±7 92.7±7 52.4±9 44.0±9 23.1±9 55.5±12 
10µg/mL 33.7±9 37.3±5 84.1±9 72.5±14 53.9±6 61.9±3 99.9±6 84.4±9 71.2±15 83.0±10 104.2±3 94.5±6 
1µg/mL 52.8±12 63.0±6 96.3±5 94.8±4 60.4±8 75.6±11 90.8±10 81.9±5 63.0±7 84.2±12 101.3±2 101.8±2 
500ng/mL 61.3±1 73.8±4 95.0±11 87.0±8 59.1±6 67.8±3 93.9±9 85.6±7 63.8±6 81.3±8 98.6±7 98.0±5 
250ng/mL 64.9±4 73.9±3 93.0±6 92.0±5 72.4±17 72.4±4 97.6±7 84.7±2 78.5±7 87.1±7 100.4±5 103.0±9 
50ng/mL 58.0±7 76.3±5 101.0±6 90.0±6 85.2±18 96.0±18 103.1±4 100.4±2 72.1±9 89.6±7 102.9±18 99.8±7 
0ng/mL 100±0 100±0 100±0 100±0 100±0 100±0 100±0 100±0 100±0 100±0 100±0 100±0 
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Figure 36 - Effect of polyelectrolyte concentration on hMSCs viability (“dose-effect” studies) obtained through 
the resazurin reduction assay. Cell viability was analysed along 7 days. The value of RFU for control is 
highlighted with a pink circle. The same control was used for the three polymers study, thus there is an overlap 
of values.  
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Figure 37 - Effect of PAH concentration on hMSCs viability obtained through the Live/Dead assay. Cell viability 
was analysed along 7 days. Red cells are dead; green cells are alive. 
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Figure 38 - Effect of ALG concentration on hMSCs viability obtained through the Live/Dead assay. Cell viability 
was analysed along 7 days. Red cells are dead; green cells are alive. 
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Figure 39 - Effect of CHI concentration on hMSCs viability obtained through the Live/Dead assay. Cell viability 
was analysed along 7 days. Red cells are dead; green cells are alive. 
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3.7 Cell encapsulation using polyelectrolyte solutions of lower 
concentration 
 A last experiment was done in the scope of the Master work which consisted in the 
encapsulation of single hMSCs within 1 bilayer of CHI/ALG (since these polyelectrolytes 
presented lower cytotoxicity than PAH) but using, in the LbL process, solutions with low 
concentrations of polyelectrolytes. Experiments were done with solutions with 
concentrations of CHI and ALG of 50ng/mL and 1µg/mL (much lower concentrations than 
the one used in the initial encapsulation experiments). As usual, the viability of the 
encapsulated cells was studied using the resazurin reduction assay and the Live/Dead 
assay. Results are shown in Table 7 and Figure 40. Once again, the cells were not able to 
retain their viability once encapsulated within the polyelectrolyte layers. 
 Overall, taking in consideration the previous and these last results, one must 
conclude that the viability of the encapsulated cells is not only dependent on the cytotoxic 
characteristics (or combined cytotoxic characteristics) of the polyelectrolytes but it seems 
that, when detached from the culture plates, the cells become too fragile and lose their 
viability very easily. Even when adherent to the cell culture plates, the simple process of 
forming multiple polyelectrolyte layers over them, gives rise to a significant lost of metabolic 
activity (Figure 32). In future experiments, special care should be taken with the 
manipulation of cells outside the incubator, for instance, maybe it is desirable to reduce the 
time of contact between the cells and the polyelectrolyte solutions and, globally, to shorten 
all the process. 
 
Table 7 - Cell viability results after 0h, 1 day and 3 days in culture using the resazurin reduction assay. hMSCs 
were encapsulated within 1 bilayer of CHI/ALG polyelectrolytes. Experiments were done with solutions with 
concentrations of CHI and ALG of 50ng/mL and 1µg/mL. Results are expressed as a percentage of the control. 
 Control 50ng/mL 1µg/mL 
0h 100±0 2.0±0 2.1±1.9 
1 day 100±0 0±3.4 0±3.6 
3 days 100±0 0±0.5 0±1.1 
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B  1µg/mL 
 
 
Figure 40 - Evaluation of the viability of hMSCs encapsulated within 1 bilayer of CHI/ALG using the Live/Dead 
assay after 0h, 1 day and 3 days in culture. Experiments were done with solutions with concentrations of CHI 
and ALG of 50ng/mL and 1µg/mL. Red cells are dead. 
(A)  (B)  (C)  
0h 1 day 3 days 
0h 1 day 3 days 
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CHAPTER 4 – GENERAL CONCLUSIONS 
 
The main objective of this project was to encapsulate single viable cells within 
polyelectrolyte films using the Layer-by-Layer (LbL) technique. Despite the various 
attempts made to achieve this goal, cells lose their viability once encapsulated, 
independently of the pair of polyelectrolytes used and of the concentration of the 
polyelectrolyte solution applied in the LbL process.  
 However, even if the objective was not fully accomplished, the work developed in 
the scope of the present Master thesis allowed interesting observations and to draw some 
conclusions, namely: 
a) It was possible to obtain single encapsulated cells via the LbL technique as proven 
by fluorescence microscopy, using fluorescent labelled  polyelectrolytes and 
staining the cell nuclei with the fluorescent dye DAPI; this possibility was tested with 
success for different pairs of polyelectrolytes (CHI/ALG, PAH/ALG and PAH/HA) 
and for different cell types (NIH 3T3 cells, rat MSCs and human MSCs); capsules 
aggregation was an observed problem which, despite the efforts to design an 
experimental procedure to avoid this situation (namely, by playing with cell 
concentration and different means of re-suspending and stirring the cells), was not 
completely overcome; 
b) Low concentration polyelectrolyte solutions should be used in future experiments 
concerned with animal cell encapsulation through the LbL technique (or whenever 
there is an interaction between the animal cells and the polyelectrolytes); one can 
concluded this from the “dose-cytotoxic effect” profiles obtained for CHI, ALG and 
PAH; this results further revealed that the PAH was the more cytotoxic 
polyelectrolyte, followed by CHI and, then, by ALG when hMSCS were used; 
c) Along the project, cell viability was assessed using the resazurin reduction assay 
(based on the evaluation of the metabolic activity of the cells) and the Live/Dead 
assay (based on the extension of cell membrane damage); due to their different 
nature, the cell viability information obtained by these methods was only correlated 
for later times after polyelectrolyte exposure; 
d)  Overall, results also point out that when detached from the culture plates, the cells 
become too fragile and lose their viability very easily; in the future, shorter methods 
(less time outside the incubator, less time in contact with the polyelectrolyte 
solutions, etc.) must be devised if the objective is to attain single viable cells 
encapsulated using the LbL technique. 
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APPENDICES 
ANIMAL CELL CULTURE (TECHNICAL ASPECTS) 
1.1 Introductory aspects 
 The culture of tissues was made for the first time, at the beginning of this century as 
a tool to study the animal cell behavior, without the influence of systematic variations. 
Usually, the term tissue culture includes cell culture of dispersed cells taken from the initial 
tissue and this process can be made by using mechanical, enzymatic or chemical methods 
[1]. 
 In 1907, the frog was chosen by Harrison as his first source of tissue, because this 
animal is a cold−blooded animal, hence the incubation was not necessary. Moreover, he 
thought that the tissue of this kind of animal, would grow more easily, comparing with 
mammalian animals, since tissue regeneration was more usual in lower vertebrates. His 
idea provided a new interest in the cultivation of tissues in vitro. However, the 
warm−blooded animals were also a field of interest, which normal and pathological 
development were closer to what happens in humans. Among different kinds of tissues, 
many of them growing well in culture, the embryonated hen′s egg was a favourite choice. 
However, with the experimental development of the animal husbandry, especially rodents, 
the mammalian come to the forefront as a better material. The rodent tissues have the 
advantage of producing continuous cell lines and a considerable set of transplantable 
tumours. The increment of transgenic mouse technology with the well−established genetic 
studies of the mouse, gave a new impulse to the selection of this animal as a favourite 
species. The human tumours can also give rise to continuous cell lines like the rodent 
tissues, which provided a new interest in human tissue, aided later by the classical studies 
of Leonard Hayflick, molecular geneticists and virologists [1].   
 The development of the cell culture occurred due to the needs of two major types of 
medical research: the production of antiviral vaccines and the understanding of neoplasia. 
The cell culture has also applications in cancer research, in the study of cell interactions 
and intracellular control mechanisms in cell differentiation and development, neurological 
and chromosomal analysis, among others [1].     
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Nowadays, there is a strong interest in growing stem cells in vitro. The stem cells 
have two important characteristics that distinguish them from other types of cells: first, they 
are unspecialized with the capacity to renew themselves for long periods of time through 
cell division to at least one daughter cell; secondly, submitted to certain physiological or 
experimental conditions, they can be induced to differentiate (these signals include 
chemicals secreted by other cells, physical contact with neighbouring cells, and contact 
with molecules in the environment), which means that they can divide themselves into cells 
with special functions. Most specialized cells present in our body (such as muscle cells, 
blood cells, or nerve cells) do not replicate themselves. The supply of these cells is 
maintained by stem cells, which replicate very often and then differentiate into specialized 
cells that are necessary. So, the cells are continuously replenished, when others die. This 
is called homeostasis [2].  
The use of stem cells is very common in bioengineering, and the major goal is to 
understand and possibly control the differentiation of these cells. If this can be reached, a 
huge amount of therapeutic applications can be considered. One potential application is the 
generation of different types of neurons for the treatment of Alzheimer’s disease, spinal 
cord injuries, or Parkinson’s disease. The production of heart muscle cells for heart attack 
survivors could also be possible. Stem cells could also be useful for a number of tissue 
engineering applications such as production of complete organs including livers, kidneys, 
eyes, hearts, or even parts of the brain. Other areas that would benefit from a better 
understanding and control of stem cell proliferation in vitro are: drug testing, cancer 
research, and fundamental research on embryonic development [3]. 
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1.2 Cell Culture 
The process of growing cells in the laboratory is known as cell culture. The cells 
divide and spread over the surface of the Petri dish (Figure 41) [1]. But this aspect will be 
referred and explained more ahead in this chapter.  
 
 
Figure 41 - Cell culture. The cells spread over the Petri dish surface. 
 
Before starting a cell culture, there are many aspects that should be considered: the 
culture environment, cell adhesion, proliferation (cell cycle), differentiation and energy 
metabolism [1]. 
 The environment on the culture influences it in three ways: (i) the nature of the 
substrate or phase on or in which the cell grow, which could be solid, (as in a monolayer 
growth on plastic), semisolid, (as in a gel such as collagen or agar), or liquid, (as in a 
suspension culture); (ii) the physic−chemical and physiological nature of the medium and 
(iii) the incubation temperature [1]. 
 Concerning cell adhesion, most of the cells from solid tissues grow as adherent 
monolayers, otherwise they are transformed or cancer cells. It was found that the cells 
have more probability to attach to or spread on glass that had a slight net negative charge. 
In addition, it was also found that the cells attach to some plastics as well, such as 
polystyrene, if the plastics were treated with an electric ion discharge or high energy 
radiation. Nowadays, it is known that the adhesion of the cells is mediated by specific cell 
surface receptors, for molecules presented in the extracellular matrix. The receptors 
involved in cell−cell adhesion are CAMs (Ca2+ independent) and cadherins (Ca2+ 
dependent). The cell substrate interactions are mediated primarily by integrins (e.g 
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fibronectin, entactin, collagen, laminin) and proteoglycans. The integrins are receptors with 
signal domain, while the proteoglycans don’t (Figure 42) [1]. 
 
 
Figure 42 - Substrate-cell and cell-cell interactions. 
 
The cell proliferation is related to the cell cycle. It is composed by four phases: M 
phase (M=Mitosis), G1 phase (G=Gap), S phase (S=Synthesis) and G2 phase (Figure 43) 
[1]. 
 
Figure 43 - Cell Cycle phases. 
  
 Very briefly, in the M phase, the chromatine concentrates into chromosomes, and 
the two single chromatids (which constitute the chromossome) separate in each daughter 
cell [1]. The Mitosis process is a phenomenon in which one cell gives rise to “daughter” 
cells, and it is constituted mainly by four stages: (a) prophase; (b) metaphase; (c) 
anaphase and (d) telophase (Figure 44) [4]. 
 In the Prophase, the chromosomes are irregularly distributed in the nucleoplasm. 
These chromosomes have two molecules of DNA strictly equal. During this phase, the 
chromosomes are shortened, becoming less thick and compact, and consequently, more 
visible. In the Metaphase, the chromosomes are located in the equatorial plan, through its 
centromeres. The Anaphase is characterized by polar rise of each “daughter” 
chromosomes (each chromatid moves to opposite poles of the cell), resulting in the 
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separation of the metaphase chromosomes. The Telophase is characterized by the 
reorganization of the nuclear membrane of the “daughter” cells, which surrounds the 
chromosomes. This phase is completed by the individualization of the “daughter” cells 
(Figure 44, Figure 45) [4].  
 
 
Figure 44 - Mitosis phases. 
 
 
Figure 45 - Mitosis of a fibroblast (skin cell). 
 
In the G1 phase, there are the synthesis of several molecules (such as enzymes, 
proteins, RNA) and the formation of many cellular organelles. In the S phase, occurs the 
DNA synthesis and replication. It is in the G2 phase, that the cell get ready for re-entry into 
mitosis [1]. 
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It is possible to control the cell proliferation. If we maintain a low cell density, cells 
are capable to spread on the plate, which means that they will enter into their cell cycle. On 
the other hand, if a high cell density remains, the proliferation is inhibited, they start to grow 
over each other and the result is the change of their shape and the reduction of spreading 
[1]. 
 For differentiation happen, some conditions are required: a high cell density, an 
enhanced cell−cell and cell−matrix interactions and the presence of several differentiation 
factors [1]. 
The energy metabolism is also important, because the cells need energy sources to 
live. Most culture media is composed by 4 to 20mM of glucose, which is used by cells as a 
carbon source for glycolysis, resulting in lactic acid as an end product. Some amino acids 
can also be used as an energy source, namely the glutamine, by the oxidation to glutamate 
by glutaminase enzyme, which allows entering to the citric acid cycle by transamination to 
2−oxoglutarate [1]. 
 The main advantages of tissue culture are the control of the physiological 
environment (pH, temperature, osmotic pressure, O2 and CO2 tension) and physiological 
conditions which can be kept relatively constant, but cannot always be defined. Other 
advantages are the regulation of the matrix, cell−cell interaction and gases diffusion; the 
availability of selective media, between others. On the other hand, there are limitations, 
such as the chemical and microbial contamination; the containment and disposal of 
biohazards; the dedifferentiation and selection; the instability, between others [1]. 
 For cell culture, there are many culture vessels. The substrate materials include 
glass and disposable plastic. The glass is the original substrate, due to its optical properties 
and surface charge, but it has been replaced by synthetic plastic (e.g. polystyrene) in most 
laboratories. The polystyrene presents a greater consistency and superior optical 
properties than glass, that’s why glass is rarely used, nowadays. However, glass still has 
some advantages like the price; it can be washed without losing its growth−supporting 
properties and can be sterilized easily by dry or moist heat. Concerning the disposable 
plastic (e.g. polystyrene), the use of this kind of material provides a simple and a 
reproducible substrate for cell culture. These materials have a good optical quality and 
present a flat growth surface, providing a reproducible and uniform culture. This substrate 
material doesn’t have a charge on its surface which provides a cell growth (hydrophobic), 
so it is treated by γ−irradiation, chemically or with an electric ion discharge to produce a 
charged surface. Other examples of plastic substrate materials are polyvinylchloride (PVC), 
polytetrafluorethylene (PTFE), thermanox (TPX), between others [1]. 
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 There many culture vessels such as: multiwell plates (6, 12, 24, and 96 wells), petri 
dishes, flasks and stirrer bottles with different sizes and capacities [1]. 
To obtain a cell growth in suspension, it can be used any kind of plate, flask or Petri 
dishes without treatment for cell attachment, but sterilized [1].   
 
1.2.1 Primary Culture and Subculture, Primary Explant 
 The term “primary culture” is relative to the stage of the culture after the isolation of 
the cells, but before the first subculture. There are three stages to refer: (i) isolation of the 
tissue; (ii) dissection and/or disaggregation, and (iii) culture after seeding into the culture 
vessel (Figure 46). After the isolation of the tissue, the primary cell culture may be formed 
by two different ways: (1) the cells can migrate from the tissue fragments, adhering to the 
plate surface and (2) the tissue can be disaggregated mechanically or enzymatically (e.g. 
trypsin, collagenase, DNase, dispase), in order to obtain a cell suspension, where some of 
them will attach to the surface plate. Most types of cells grow attached to the plate surface, 
otherwise, they are transformed cells (implies a spontaneous or induced permanent 
phenotype change), which survive and proliferate in suspension. The attachment of cells to 
each other and to the surface plate is caused by the presence of glycoproteins and Ca2+, in 
their surface. The presence of adhesion and antitrypsin factors in the serum also 
contributes to cell attachment [1, 5]. 
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Figure 46 - Scheme about Culture of animal cells. 
 
The first “subculture” (or passage, or transfer) is very important to the cell culture. 
To proceed with the subculture, the surface plate of the primary culture must be all 
occupied with cells (confluence). There are other reasons to proceed with a subculture, 
such as: the exhaustion of culture medium; the time since the last subculture and when the 
cells are needed for other experimental procedures. The passage number represents the 
number of times that the culture was subcultured. The color of the medium can indicate if 
the cells need to be subcultured or not (when the color medium becomes less reddish) [1, 
5]. 
Relatively to the “primary explants”, this technique is especially useful for small 
amount of tissue, where it is risky to lose most of the cells in the enzymatic or mechanical 
procedures. It can be any part of the tissue from an animal. Briefly, the tissue is handled in 
a sterile ambient (Figure 47); usually the tissue should be minced (1), and the pieces are 
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put in a cell culture dish, containing culture media (2). Over time, the progenitor cells 
migrate out of the tissue onto the surface of the dish (3). These primary cells can then be 
further expanded and transferred into new Petri dishes [1, 5]. 
 
 
 
 
 
                                                               
 
Figure 47 - Schematic procedure of an explants (human bronchial epithelial cells grown from explants). 
  
(1)  (2) 
(3) 
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1.2.2 Cell Lines 
 A cell line represents a primary culture after the subculture. The attainment of a cell 
line from a primary culture requires: (a) an increase in the total number of cells during 
several generations and (b) the predominance of cells or cell lineages with the capacity for 
high growth, resulting in (c) a degree of uniformity in the cell population [1]. 
 The next scheme show the ways how can we create a cell line (Figure 48).  
 
 
Figure 48 - How can a cell line be derived? 
 
 The cell lines can be propagated as an adherent monolayer or in suspension. The 
monolayer culture means that the cells will grow attached to a substrate (they are 
anchorage dependent, which means that it is necessary a substrate for cells proliferation). 
This kind of culture is the most common one, except for hematopoietic cells. On the other 
hand, the suspension culture doesn’t require a substrate for cells growth, they have the 
ability to survive and proliferate without attachment (anchorage-independent). This type of 
culture is only applied for certain kinds of cells, such as hematopoietic cells (like was 
referred before), transformed cells lines and for malignant tumour cells [1]. 
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1.2.3 Cell Growth Curve  
 After the subculture, the cells obeys to a pattern growth, which can be represented 
in a graph (Figure 49), constituted by three stages: (i) lag phase; (ii) exponential or log 
phase and (iii) stationary or plateau phase [1, 5]. 
 
Figure 49 - Growth curve of bacteria (for instance). 
 
Briefly, the lag phase corresponds to the adaptation of the cells, where they replace 
the adhesion factors lost by the trypsinization process, attach again to the surface plate 
and spread out. 
During spreading, the cells also synthesize again new DNA and structural proteins. 
The exponential or log phase represents the period of an exponential growth, increasing a 
lot the number of cells. This growth will depend on the seeding density and the growth rate 
of the cells, mainly. Relatively to the last phase, the growth rate is reduced, which means 
that the surface plate is confluent (when all the surface plate is occupied by cells again). In 
this case, the cells must be passed to another plate, if it doesn’t happen the cells will die 
(“Death Phase”) [1, 5]. 
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1.2.4 Cell Medium 
 The cell medium depends of the type of the cells. Eagle’s Minimal Essential Medium 
[Eagle, 1959] is the mostly used, variously supplemented with human, horse or calf serum, 
protein hydrolysates, and embryo extract [1].  
 In the development of a media, there are many physicochemical properties to be 
considered: pH, CO2 and bicarbonate, buffering, oxygen, osmolality, temperature, viscosity, 
surface tension and foaming. Giving emphasis to the pH, most of cell lines grow well at 7.4. 
However, for some types of cells, the pH changes a little bit. For example, for normal 
fibroblast lines, the optimum pH is between 7.4-7.7, while for the transformed ones, the 
better pH is between 7.0-7.4. The CO2 % is also important, because as a buffer, it tends to 
maintain a relatively constant pH and it can counteract any force that would change it. In 
this system, the carbon dioxide (CO2) combines with water to produce carbonic acid 
(H2CO3), which in turn, rapidly dissociates to originate hydrogen ion and bicarbonate 
(HCO3-), according to the reaction below [1]. 
 
H2O + CO2           H2CO3          H+ + HCO3-   
 
The media is constituted by many components: aminoacids (e.g. L-alanine, L-
histidine, L-proline; between others), vitamins (e.g. folic acid, biotin, menadione, riboflavin, 
between others), salts (e.g. CaCl2, KCl, MgSO4, between others), antioxidants 
(glutathione), bases and nucleosides (e.g. adenosine, ATP, thymine, cytidine, between 
others), lipids (e.g. cholesterol, lipoic acid, linoleic acid, between others), glucose, between 
others components [1]. 
The amounts of each component will depend of the type of the medium and to 
which kind of cell is destined. The concentration of the amino acids normally limits the 
maximum cell concentration that it is possible to be attained, and the balance could 
influence the cell survival and the growth rate. The glucose is present in most culture 
medium, as a source of energy. This sugar is metabolized mainly though glycolysis to 
produce pyruvate, which could be converted to lactate or acetoacetate and can be used in 
the citric acid cycle to form CO2 [1, 4].  
The final medium also contains serum (10%, usually) which contributes with growth 
factors for cell proliferation and with adhesion factors, which promote cell attachment. The 
most used types of serum are from calf, fetal bovine, horse or human. Serum is also a 
source of minerals (e.g. calcium, potassium), lipids (e.g. fatty acids, phospholipids) and 
hormones (e.g. insulin, hydrocortisone). The preparation of the culture medium also 
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includes beyond serum, the antibiotics (1%, normally) (usually penicillin and streptomycin), 
to avoid contamination sources (Figure 50) [1]. 
Although, if it is used properly equipments like the laminar-flow chamber, jointly with 
an aseptic technique, the addition of antibiotics in the medium is unnecessary. Even 
because, the antibiotics have some disadvantages, like: (a) they allow the appearance of 
antibiotic-resistant organisms; (b) they posses antimetabolic effects that could provide 
crossreactivity in mammalian cells; (c) they encourage for not utilize an aseptic technique, 
accordingly [1].  
 
 
Figure 50 - Alpha-MEM; Serum; Antibiotics: Penicilin and Sptreptomicin, respectively. 
 
1.2.5 Cell Counting 
 A hemacytometer is a graduated counting chamber that can be visualized under a 
microscope, to determine the concentration of cells in suspension. It is used usually for 
counting blood cells, but these chambers are widely used also in cell culture to determine 
the concentration of cells in a suspension. This equipment has some style variations. The 
most common one is called “Neubauer” type chamber. The instrument is made of ground 
glass with a central area that is defined by a set of grooves that form an ‘H’ shape. Two 
counting areas with ruled grids are separated by the horizontal groove of the H. The glass 
coverslip is held at 0.1 mm above the surface of the counting areas by ground glass ridges 
on either side of the vertical grooves of the H shape (Figure 51, Figure 52) [6]. 
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Figure 51 - Neubauer chamber. 
 
 
Figure 52 - Scheme where it is possible to see the counting area. The blue cells are non-viable (when stained 
with trypan blue, and visualized in a Microscope), the other ones are viable [6]. 
 
1.3 Aseptic technique 
 The contamination by microorganisms such as bacteria, mycoplasma, yeast and 
fungal spores still is the major problem in tissue culture. These microorganisms may be 
introduced through the operator, the work surfaces, the solutions, the atmosphere, among 
other sources. A correct aseptic technique should provide a barrier between 
microorganisms in the environment outside the culture and the “pure” (uncontaminated 
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culture within its flask or dish). Hence, all the materials that will interact directly with the 
cells must be sterilized. So, aseptic technique is a combination of procedures in order to 
reduce the probability of infection [1]. 
 The elements of an aseptic environment include quiet area, work surface, personal 
hygiene, reagents, media and cultures [1]. 
 It is advisable to choose a quiet area with little or no traffic and no other activity, in 
absence of laminar flow hood. With this equipment, the picked area should be restricted to 
tissue culture, free of dust, clean and should not contain other equipments not related to 
tissue culture [1].  
About the work surface, it must be clean every time, it should be swabbed with 70% 
alcohol. Other rules should be considered such as, mop up any spillage immediately and 
swab the area with 70% alcohol and only bring the material needed to a particular 
procedure. After finishing the work, everything should be removed and the work surface 
should be swabbed down again [1]. 
 Washing hands will reduce adherent microorganisms, which are the most risk for 
cells cultures. Gloves can be used and swabbed frequently with ethanol. The hair should 
be tied back, if it is long and the operator shouldn’t talk if he’s working in an open bench [1]. 
 Reagents and media obtained commercially already have undergone to a strict 
quality control to ensure that they are sterilized. For the prepared solutions, they should be 
sterilized in the lab (autoclave). All the reagents bottles should be swabbed with alcohol 
before using inside the laminar flow hood [1].  
About the cultures, they should be handled properly, which means that they must 
remain the less time possible outside the incubator, because when they are inside the 
laminar flow chamber, the % of oxygen and temperature decrease and these factors can 
contribute to the cell death.  Other important detail is that the dish or cell plates shouldn’t 
be completely closed, to allow the gas exchange between the cells and the environment 
[1]. 
   
1.4 Equipments in cell culture 
1.4.1 Autoclave 
The most used equipment to sterilize glassware and other materials is the autoclave 
(Figure 53).  An autoclave is an airtight, steel pressure vessel used to heat substances 
under high pressure in chemical and industrial processes [7]. This equipment gives an 
automatic, programming and safety locking, which provides more flexibility [1].  
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Figure 53 - Autoclave Equipment. 
   
 Each autoclave installation is composed of the autoclave itself, along with its 
auxiliary equipment and systems, including: a vacuum system, a thermocouple system, a 
heating system, a pressure system, a control panel, a computer or PLC (programmable 
logic controller) system, an instrumentation system, a datalogging system and safety 
systems. Of course that there are many models of autoclaves, some of them don’t have all 
the components referred before [7]. 
 Before sterilization, the glass material should be capped with foil, as well as some 
plastic materials. The most plastic materials are isolated inside plastic little bags, closed 
hot. All this procedure should be done, using gloves [1]. 
 
1.4.2 Laminar flow hood 
 A laminar flow hood is an equipment where we can work without contamination. The 
environment inside the chamber is protected because it has constant stable flow of filtered 
air (HEPA) passing over the work surface (Figure 54) [1].  
 There are two main kinds of flow: horizontal and vertical. In the first one, the airflow 
blows from the side facing the operator, parallel to the work surface while whereas in the 
vertical, the airflow blows down from the top of the chamber onto the work surface and is 
drawn through the work surface. The horizontal flow hood provides the best sterile 
conditions for the cell culture and reagents. Besides, it is cheaper than the vertical one. On 
the other hand, the vertical chamber gives more protection to the operator. The equipment 
surfaces must be clean regularly, with 70% alcohol, mainly after being used [1]. 
 This equipment also requires a UV light, which should be turned on during 20 
minutes before using it and turned off before starting to use the laminar flow hood. This UV 
light will exterminate the organisms which can be a source for contamination [1]. 
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Figure 54 - Laminar Flow Chamber. 
 
1.4.3 CO2 Incubator 
 The incubator is the equipment where we can keep the cell culture vessels, in 
optimum conditions for their maintenance (Figure 55). These conditions are related mainly, 
to the CO2 % and the temperature. Usually, the temperature is about 37ºC (physiological 
temperature), and 5% of CO2 is maintained in the air environment. These equipments 
should be cleaned weekly or monthly, by removing all the contents (including the trays and 
the shelves), with usually 70% ethanol [1]. 
 
Figure 55 - Incubator representation. 
 
1.5 Cryopreservation 
 Cryopreservation is a process where cells or whole tissues are preserved, by 
cooling them in low sub-zero temperatures, such as (usually) 77K or −196 °C (the boiling 
point of liquid nitrogen) (using special dewars) (Figure 56). At these low temperatures, 
everything that would lead to cell death is stopped (biological activities, including the 
biochemical reactions). This phenomenon can cause damage to cells, mainly during the 
freezing stage, problems like: intracellular and extracellular ice formation and dehydration. 
Many of these effects can be reduced by using cryoprotectors agents [5].  
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There are many factors which advance a good cell survival, after freezing and 
defrosting, some of them are: (i) the cell density at freezing should be between 1x106 and 
1x107 cells/mL; (ii) the presence of DMSO or glycerol (5-10%) to protection; (iii) the slow 
cooling: 1ºC/min, down to -70ºC and then a rapid transfer to liquid nitrogen freezer; (iv) the 
rapid defrosting, among others [5]. 
 
 
 
Figure 56 - N2 (l) bottle. 
 
1.6 Inverted Fluorescence Microscope 
 An inverted fluorescence microscope is a useful tool to visualize and study cells. 
Fluorescence techniques are suitable for probing living cells, due to their sensitivity and 
specificity. An image and a photometric signal can be obtained, from a single cell, so this 
kind of microscopy has a great potential for qualitative and quantitative analysis related to 
the structure and functions of the cells. The most important advances which contribute to 
the use of this technique for single living cells are: (i) probes for specific structures or 
environmental parameters; (ii) methods for delivering fluorescent probes into living cells 
and (iii) methods for detecting weak fluorescence signals for living cells [8, 9].   
 Nowadays, fluorescence microscopy is one of the most important tools for the 
examination of the cells and cellular constituents. Fluorescent probes and fluorescently 
marked immunological probes give us the ability to visualize and quantify basic structures 
within the cells [8, 9]. Concerning its operation, in most cases the sample of interest is 
labeled with a fluorescent substance known as a fluorophore and then illuminated through 
the lens with the higher energy source. The illumination light is absorbed by the 
fluorophores (attached to the sample) and causes them to emit a longer lower energy 
wavelength light (Figure 57) [8, 10]. 
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Figure 57 - Left: Fluorescence Microscopy; Right: Fluorescence Microscopy mechanism [10]. 
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The work was written using ‘Arial’ letter type, with size 11, and a spacing of 1.5 between 
lines. The pages margins are: left: 3cm; right: 2.3cm.  
 
Two different softwares were used: “NIS-Elements AR” (Fluorescence Microscopy) and 
“Wallac 1420 Workstation” (Microplate Reader). For the treatment of some images 
obtained from the Fluorescence Microscope, the ImageJ Program was used. 
